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Abstract 
Oxocarbenium ions are common intermedates or transition states for a variety of 
biological and synthetic transformations. Due to the fact that oxocarbenium ions are 
typically much more reactive than iminium ions, their reactivity is difficult to control. 
Especially challenging reactions of oxocarbeniums are stereoselective transformations. 
While there are several approaches to perform reactions of oxocarbeniums asymetrically, 
the Nagorny group is particularly interested in using chiral hydrogen bond donors and 
Brønsted acids as catalysts for these reactions.  
Chapter 1 of this thesis provides an introduction to chemistry of oxocarbenium ions, 
their generation and use in asymmetric reactions. Both anion activation and protonation of 
acetals and vinyl ethers with chiral hydrogen bond donors and chiral Brønsted acids are 
covered in this chapter.  
Chapter 2 discusses ionic Diels-Alder reaction as well as the use of 
thiophosphoramide as a co-catalysts for promoting this transformation. 
Thiophosphoramide catalyst was found to bind sulfonate anions and was used to separate 
the vinyl oxocarbenium/sulfonate ion pair. This effect leads to acceleration of the Diels-
Alder reaction of unsaturated acetals. Thiophosphoramides are the most effective 
cocatalysts because of the stronger counterion activation effect resulting from three, rather 
than two, hydrogen bonds involved in anion binding. 
xvi 
 
Chapter 3 of this manuscript describes development of the first chiral catalyst-
controlled enantioselective ionic Diels-Alder reaction of unsaturated acetals. Chiral 
BINOL-based N-triflylphosphoramides were used as catalysts for this transformation. This 
reaction proceeds through the intermediacy of a vinyl oxocarbenium/chiral anion pair, and 
the chiral N-triflylphosphoramide anion controls the stereoselectivity of the cycloaddition 
step. Moderate enantioselectivities (up to 80:20 e.r.) have been obtained when α,β-
unsaturated dioxolanes were employed as the dienophiles. These reactions demonstrate 
strong dependence on the counterion coordinating properties and solvent polarity, a 
behavior characteristic of oxocarbenium ions.  
Finally, Chapter 4 describes attempts of stereo- and regioselective aminoglycosides 
via desymmetrization of meso-2-deoxystreptamine using chiral phosphoric acids as 
catalysts. We were able to show that chiral phosphoric acids facilitate desymmetrization of 
meso-diols via glycosylation reactions using mannose-α-trichloroacetimidate. Chiral 
phosphoric acid-promoted mannosylation of 2-deoxystreptamine produces a mixture of 
two α-mannosides. While (R)-enantiomer typically leads to glycosylation of 2-
deoxystreptamine derivative with modest regioselectivities and a major regioisomer having 
glycosylation at O-4 (natural) of 2-deoxystreptamine, (S)-enantiomer favors glycosylation 
at O-6 with selectivities up to 1:5 (O-4 : O-6). This is the first report of desymmetrization 
of meso-diols via glycosylation using chiral phosphoric acids as catalysts. This method has 
a potential to be applied for glycodiversification of 2-deoxystreptamine and synthesis of 
new aminoglycoside antibiotics.  
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Chapter 1 
Hydrogen Bond-Catalyzed Reactions of Oxocarbenium Ions 
1.1 Introduction into Chemistry of Oxocarbenium Ions 
An oxocarbenium ion is a carbocation, real or hypothetical, stabilized by electron 
pairs of neighboring oxygen atoms. Oxocarbeniums are common intermediates or 
transition states for many biological and synthetical processes (e.g. hydrolysis of 
glycosydic bonds, reduction of acetals, Diels-Alder reactions etc). The general structure of 
an oxocarbenium ion contains an oxygen-carbon double bond with the oxygen atom 
attached to another substituent. This structure has a formal positive charge that is placed 
on an oxygen atom. Being more highly polarized than typical carbonyls, they are far more 
reactive towards the addition of nucleophiles. A carbonyl can be activated with a Lewis 
acid coordination to oxygen, the smallest of which is a proton. The resulted structure can 
be considered an oxocarbenium ion if the full proton transfer occurs. An average dipole 
moment for a general ketone R2CO is calculated to be δ = 0.51, while a fully protonated 
ketone [R2COH]
+ has a dipole moment of δ = 0.61.  
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Lewis acid coordination to a carbonyl group can lead to formation of structures 
with a range of oxocarbenium ion character. The amount of positive charge on oxygen is 
determined by a number of factors but mainly by the strength of the bond between the 
Lewis acid and oxygen ranging from very weak electrostatic interactions to covalent bonds. 
That is why here we will focus only on oxocarbenium ions where oxygen is covalently 
bound to a carbon atom. Generation of oxocarbenium ions 1-3 can be achieved by either 
complete protonation of vinyl ethers 1-1 by strong Brønsted acids (Scheme 1,1, Path I) or 
by promoting leaving group dissociation from α-functionalized ethers 1-2 (Path II). Such 
dissociation can be promoted by both weakly acidic hydrogen bond donors and stronger 
Brønsted acids. Fully protonated carbonyls also have oxocarbenium ion character, however 
activation of carbonyls with chiral Brønsted acids has been recently reviewed1 and will not 
be discussed here.  
Scheme 1.1 Generation of oxocarbenium ions 
Within the field of asymmetric catalysis, a variety of methods have been developed 
for highly enantio- and diastereoselective reactions of imines, as well as aldehydes and 
ketones. Many of these methods rely either on Lewis or Brønsted basicity of the 
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electrophilic substrates to bind chiral catalysts. Oxocarbenium ions are missing the Lewis 
basic site to bind the acidic catalyst, thus requiring other modes of controlling facial 
selectivity in such reactions. In addition to that, imines are far more basic than carbonyl 
compounds, making it easier to bind the acidic chiral catalyst. Finally, controlling reactions 
of oxocarbenium reactions is far more challenging2 than of iminium ions due to high 
electrophilicity and reactivity of the former. It was our objective to study reactivity of 
oxocarbenium ions with the possibility to develop stereoselective reactions of 
oxocarbeniums. 
1.2 Hydrogen bond catalysis 
Over the past few decades enantioselective organocatalysis has emerged as an 
important paradigm for numerous stereoselective organic transformations. Hydrogen bond 
and Brønsted acid catalysis is one of the subfields of organocatalysis. Hydrogen bond 
donors possess the ability to coordinate to basic sites in substrate molecules, thus forming 
complexes with variable degrees of proton transfer.3,4,5 Organocatalysis, including 
hydrogen bond catalysis offers several advantages over Lewis acid catalysis. While many 
Lewis acid/base interactions are stronger and more directional, electrophilic activation by 
H-bond donors has also emerged as a powerful tool in asymmetric catalysis. H-bond 
catalysis typically does not use metals, making a contribution to green chemistry. 
Additionally, H-bond catalysts are typically non-toxic, shelf stable, as well as they offer 
promising advantages of immobilization on a solid phase.6 
The relatively strong intramolecular interactions of molecules bearing X-H bonds, 
with proton acceptors A, were observed as early as the 19th century. Some of the examples 
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are Faraday’s discovery of chlorine hydrate in 1823, while Nernst investigated the 
properties of molecules containing hydroxy groups. Huggins, Pauling, Bernal, Latimer, 
and Rodebush were among the first to recognize the generality of this phenomenon, and 
gave rise to the modern concept of H-bonding.7 The definition of the H-bond was recently 
provided by Steiner: 
“An X−H···A interaction is called a ‘hydrogen bond’, if 1) it constitutes a local 
bond, and 2) X−H acts as a proton donor to A.”8 
Hydrogen bond is a phenomenon that is very complex and chemically variable. 
Based on theoretical studies, hydrogen bond energies cover more than two orders of 
magnitude, about −0.2 to −40 kcal/mol. Hydrogen bonds have been subdivided to three 
categories: weak, moderate, and strong (Table 1.1). Since the maximum bond strength can 
be observed when X−H···A is 180°, this effect is mostly pronounced in strong hydrogen 
bonds, and is more relaxed in the case of moderate and weak H-bonds. The physical basis 
of hydrogen bonds also differs going from strong to weak interactions. While strong H-
bonds are mostly considered to have covalent bonding character, moderate and weak 
hydrogen bonds are typically described as electrostatic interactions.9  
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Table 1.1 Properties of hydrogen bonds and their examples7 
Despite the long history of hydrogen bond and Brønsted acid catalysis, its 
asymmetric variations are relatively recent. The interest in Brønsted acid catalysis was 
reborn in the 1990’s when weakly acidic hydrogen bond donors such as water and urea 
were shown to catalyze some organic transformations.10 This discovery roughly coincided 
with major progress in understanding the role of H-bonding in the function of different 
classes of enzymes.11  
1.3 Anion Activation 
Studies of the mechanism of action of various enzymes identified hydrogen 
bonding as a key element for activation of various electrophiles, either through 
coordination to electrophiles, or through anion activation7,12 (Scheme 1.1, Path II). 
Independently, small molecule hydrogen bond donors were discovered to catalyze a variety 
of organic transformations through the same type of activation. The pioneering studies on 
this topic were published by Hine and co-workers. They identified biphenols and 
biphenylenediols as catalysts for nucleophilic addition of amines to epoxides.13 Soon a 
variety of different H-bond donors such as ureas, thioureas, squaramides, BINOLs, 
TADDOLs, etc. were developed and used for anion activation type of catalysis. 
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Scheme 1.2 Acetalization of carbonyls through stabilization of oxyanion 
One of the first synthetic examples of anion activation using hydrogen bond donors 
was provided by Schreiner and Kotke. They reported an extremely efficient acetalization 
method of a variety of carbonyl compounds using thiourea 1-4 (Scheme 1.2). Their 
mechanistic studies showed that thiourea aids in the heterolysis of an orthoester stabilizing 
the oxyanion.14 Chiral variants of weakly acidic hydrogen bond donors were soon 
developed.15 Thus, pioneered by Prof. Eric Jacobsen, chiral ureas and thioureas were found 
to effectively promote dissociation of various leaving groups such as cyanides and 
chlorides,16b resulting in cation/chiral anion pairs that subsequently undergo 
enantioselective nucleophilic attack. While successful in enantioselective reactions 
proceeding through iminium ions were developed,16 it was not immediately clear whether 
the same mode of activation would be applicable to more reactive oxocarbenium species. 
Unlike iminium ions, O-substituted oxocarbenium ions are typically more difficult to 
generate, are highly reactive, and can only be loosely coordinated to the chiral anion, 
impeding asymmetric induction. Development of stereoselective reactions of 
oxocarbenium ions thus presents a challenge.  
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Scheme 1.3 Enantioselective addition to 1-chloroisochromans 
The first example of enantioselective oxocarbenium ion reaction catalyzed by H-
bond donor was reported by the Jacobsen group (Scheme 1.3).17 Treating 1-chloro-
isochromans 1-5 with silyl ketene acetals and chiral thiourea 1-6  afforded alkylation 
products 1-8. Methyl- and fluoro- substituents on the benzene ring of 1-chloro-isochroman 
were well tolerated, while addition of an electron-donating methoxy group at C-6 resulted 
in a moderate decrease in enantioselectivity, yet slightly increased yield (74% ee, 96% 
yield). Additionally, substitution on the silyl ketene acetal was well tolerated, providing 
α,α-disubstituted esters in high yields and enantioselectivities. Based on previous 
mechanistic studies on the addition of silyl ketene acetals to carbenium ions,18 as well as 
on the complete reaction inhibition with nBu4NCl, authors suggested a mechanism 
involving formation of oxocarbenium 1-7/[1-6•Cl]- ion pair.  
While the aforementioned cases involve direct nucleophilic addition to the 
electrophilic carbon, hydrogen bond donors also promote oxocarbenium cycloaddition 
reactions (Scheme 1.4). In 2011 Jacobsen reported a protocol for enantioselective [5+2] 
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cycloaddition of pyrylium ions.19 To generate the pyrylium ion, p-thiomethylbenzoyl 
pyranones were treated with a mixture of Schreiner’s thiourea 1-4 and chiral thiourea 1-10 
(Scheme 1.4). High yields and enantioselectivities were achieved with substrates 
possessing olefin substitution on the terminal C atom (1-9), including allenes. Other modes 
of substitution were not tolerated well, providing low to no reactivity. Computational and 
experimental data support the intermediacy of aminopyrylium ion 1-11 forming via imine 
condensation between pyranone 1-9 and NH2 group of 1-10, followed by the loss of 
p-methylthiobenzoate. Although the substrate scope is rather limited by low reactivity, 
covalent binding of the chiral urea to the substrate explains high enantioselectivities 
achieved. It is possible that low reactivity is the consequence of the inherently low 
electrophilicity of the aromatic aminopyrylium ion. The covalent binding between the 
chiral catalyst and the substrate provides an exciting future opportunity for enhancing the 
electrophilicity of the intermediate. 
While H-bond donor ligands used for supramolecular purposes (such as anion 
recognition, anion transport, molecular cages etc.) typically provide the source for multiple 
hydrogen bonds, most of the hydrogen bond donors used in organocatalysis can 
simultaneously donate only up to two hydrogen bonds. Bifurcated H-bonding interactions 
benefit from increased strength and directionality relative to single hydrogen bond. 
Generally, any Lewis base is capable of engaging in bifurcated hydrogen bond. 
Electrophiles containing such groups as carbonyls, imine derivatives, N-acyliminium ions, 
and nitro compounds can all be activated by double-hydrogen bond donors.  
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Scheme 1.4 Cycloaddition reactions of oxocarbenium ions 
Since the development of chiral thiourea by Jacobsen, there has been an explosion 
of research activity in the field of hydrogen bond catalysis. The H-bond donor catalysts 
now possess a wide range of structural and functional motifs (Figure 1.1). These catalysts 
differ widely in the mechanisms of electrophile activation and catalysis, as well as their 
acidities.  
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Figure 1.1 Examples of hydrogen bond catalysts20 
1.4 Protonation 
As it was mentioned previously, electrophiles can be activated either through 
coordination to electrophiles, or through anion activation. Hence, coordination to 
electrophiles can be achieved with either Lewis or Brønsted acids. Since 1990s, chiral 
Brønsted acids have become popular catalysts for enantioselective synthesis due to the 
ubiquity of acid catalysis in organic transformations. Enantioselective Brønsted acid 
catalysis relies heavily on chiral inductions originating from chiral counter-anion or chiral 
counter-anion complexes. Therefore, the manipulation of chiral anions, by either structural 
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modification or strategic complexation, represents the most practical approach for the 
evolution of chiral Brønsted-acid catalysis.21  
In 2004 a new group of chiral Brønsted acid organocatalysts was introduced by 
Akiyama and Terada. They independently reported synthesis of strong BINOL-derived 
chiral phosphoric acids (CPAs) and their application to Mannich-type reactions.22,23 Chiral 
phosphoric acids and their derivatives quickly became the most popular class of chiral 
Brønsted acids due to their high acidities and relative ease of structure modification.  
The most widely used group of chiral phosphoric acids, is based upon a rigid C-2 
symmetric BINOL scaffold (Figure 1.2). The binaphthyl moiety is most frequently 
modified by changing substituents at positions 3 and 3’ which allows adjustment both of 
the steric properties around the substrate recognition site as well as pKa of the phosphoric 
acid. In addition, the steric environment around the phosphate functionality may be 
attenuated by using H8-BINOL rather than BINOL-based backbone. The OH group (Y = 
OH in Figure 1.2) on phosphorus acts as an acidic hydrogen-bond donor, and in some cases 
the phosphoryl oxygen (X = O in Figure 1.2) can also act as a hydrogen bond acceptor.  
The pKa of chiral phosphoric acids may range from 14 to 12.5 (in acetonitrile)
24, 
which is usually acidic enough to activate electrophiles such as imines or aziridines. 
However, chiral phosphoric acids are not as effective in coordinating to less basic 
functional groups. Ever since CPAs were introduced, there have been many attempts to 
increase their acidity in order to activate less reactive electrophiles. Because thioacids are 
known to be somewhat more acidic than the corresponding oxoacids, a diverse group of 
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thiophosphoric acids (Figure 1.2, X = S/O; Y = S) was synthesized and applied to 
enantioselective catalysis.25  
Figure 1.2 Structure and acidities of chiral phosphoric acids and N-triflamides 
In 2006, Yamamoto and co-workers proposed a new group of highly acidic CPA 
derivatives.26 The introduction of a strongly electron withdrawing N-triflamido group in 
place of the hydroxyl group furnished catalyst, which was sufficiently acidic to activate 
α,β-unsaturated ketones. This acid proved to be an excellent enantioselective catalyst for 
the Diels-Alder reactions between α,β-unsaturated ketones and reactive dienes and many 
other cases where a stronger Brønsted acid was desired. Further titration studies performed 
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by Rueping and co-workers showed, that pKa values of N-triflylphosphoramides range 
between 6 and 7.24 
Advances in chiral phosphoric acids and their derivatives allowed chemists to 
develop a variety of stereoselective reactions including reactions of oxocarbenium ions. In 
this case activation of an electrophile proceeds through complete protonation of a vinyl 
ether or an acetal. Thus, in 2009 Terada reported enantioselective addition of a carbon-
nucleophile to an oxocarbenium ion catalyzed by chiral phosphoric acid (Scheme 1.5).27 
To form the oxocarbenium ion and promote direct aldol-type addition, vinyl ethers were 
treated with a chiral phosphoric acid 1-15 in the presence of azlactones 1-14. Chiral 
phosphoric acids are much stronger hydrogen bond donors than thioureas, hence 
substantial protonation of the vinyl ether can be achieved. Enantio- and 
diastereoselectivities were determined after aldol adducts were treated with sodium 
methoxide in methanol to provide the corresponding methyl esters 1-16. 
In this reaction, Ar2 substitution has a substantial effect on the reaction yield, as 
well as on both enantio- and diastereoselectivity. Thus, when electron-donating methoxy- 
substituents were present (Ar2 = 3,5-(MeO)2C6H3), the corresponding products were 
obtained in higher yields and stereoselectivities. Additionally, sterically demanding tert-
butyl ether (R1 = tBu) was essential for selective formation of the syn stereoisomer. 
Substituent Ar1, however, was shown to have almost no effect on enantio- and 
diastereoselectivity. While Terada showed that chiral phosphoric acids can indeed catalyze 
stereoselective nucleophilic addition to vinyl ethers, the effects of the substrate substitution 
on the product diastereoselectivity are rather substantial. It should be noted that the range 
of available chiral Brønsted acids has significantly expanded since the original report by 
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Terada, and the stereoselectivity issues may plausibly be resolved by newer catalysts. 
Additionally, a more convincing evidence for the intermediacy of oxocarbenium ions in 
this reaction is desirable. 
Scheme 1.5 Aldol-type reaction of vinyl ethers by Terada 
Since Terada’s report on the enantioselective nucleophilic addition to vinyl ethers 
(vide supra), chiral phosphoric acids and their derivatives became important catalysts for 
promoting stereoselective reactions of oxocarbenium ions. Tu and coworkers used the 
same chiral phosphoric acid 1-15 for a conceptually similar approach to enantioselective 
semipinacol rearrangement (Scheme 1.6).28a This method allowed easy access to chiral 
spiroethers, a structural motif found in a selection of biologically significant drugs and 
natural products. To produce chiral spiroethers 1-19, cyclic vinyl ethers 1-17 were treated 
with either chiral phosphoric acid (R)-1-15 or its Ag salt. Here the chiral silver phosphate 
participates in Ag-proton exchange with the starting allyl alcohol, forming (R)-1-15 in situ. 
Although geminal substitution at the C5 of dihydropyranyl (1-19b) ring was well tolerated, 
geminal substitution at the C4 (1-19c) or C6 resulted in decreased enantiocontrol (77-87% 
ee). The reaction was tentatively proposed to proceed through oxocarbenium ion 1-18, 
however no detailed mechanistic data are available to support this hypothesis. Since the 
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current study involved only substrates with gem-dialkyl or -diallyl substitution, additional 
studies would be necessary to fully define the substrate scope of this reaction. This 
methodology would have also benefited from applying it to the synthesis of spiroethers 
structurally similar to naturally occurring motifs.  
Scheme 1.6 Semipinacol rearrangement by Tu 
Addition of oxygen nucleophiles to oxocarbenium ions leads to formation of cyclic 
and acyclic O,O-acetals, including glycosides, saccharides, and spiroketals, which are 
ubiquitous among practically important natural and synthetic organic compounds. 
Asymmetric acetal synthesis presents a considerable challenge due to lability of the 
products under the reaction conditions, as well as due to weak interactions of the 
oxocarbenium with the chiral fragment. The propensity of product acetals to ionize to 
oxocarbenium ions can be partially moderated by limiting the Brønsted acidity of the 
catalyst.29 It should be noted, however, that even relatively strongly acidic chiral 
phosphoric acids are known to be efficient catalysts for the stereoselective formation of 
O,O-acetals (vide infra).24,30 
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Scheme 1.7 Asymmetric transacetalization by List 
The first protocol for enantioselective formation of O,O-acetals by intramolecular 
transacetalization was reported by the List group (Scheme 1.7).31 Remarkably, TRIP-based 
phosphoric acid (S)-1-15 was again found to be the most powerful catalyst, providing 
excellent enantioinduction. Aliphatic (1-21a) and aromatic (1-21b) geminal substituents 
are tolerated equally well, affording mixed acetals in high yields and enantioselectivities. 
Formation of unsubstituted acetal 1-21c was less enantioselective (58% ee), apparently due 
to the smaller substrate size. Lower stereoselectivity was also observed for six-membered 
acetal formation (1-21d, 64% ee). 
Scheme 1.8 Glycosylation catalyzed by CPAs 
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A contemporaneous report by the Fairbanks group demonstrated the first chiral 
phosphoric acid-controlled β-selective glycosylation (Scheme 1.8).32 While the reaction 
proceeded with good to excellent β-selectivity, it is not immediately clear whether this 
observation is entirely due to the effects of the chiral catalysts, since some stereocontrol by 
the chiral substrate might be anticipated. Later examples show that chiral phosphoric acids 
can also be utilized for regioselective acetylation and glycosylation of polyols, as well as 
for glycosylative chiral resolution of alcohols (see chapter 4). 
Spiroketals are important motifs that are often present in biologically active natural 
products. Racemic synthesis of thermodynamically more stable spiroketals is well 
developed. However, until recently, no direct chiral catalyst-controlled methods were 
available for stereoselective synthesis of thermodynamic and non-thermodynamic 
spiroketals.33 Contemporaneously with the List group, our  group identified that chiral 
phosphoric acids can be used as catalysts for enantioselective and diastereoselective non-
thermodynamic synthesis of spiroketals without promoting significant epimerization at the 
anomeric position (Scheme 1.9). 
The List group aimed at stereoselective synthesis of unfunctionalized, sterically 
undemanding spiroketals.34 Cycloisomerization of cyclic enol ethers possessing tethered 
alcohol moieties (1-23) was promoted by Brønsted acids. Since the most popular chiral 
phosphoric acids such as 1-15 provided unsatisfactory enantioselectivities for such small 
substrates, a variety of chiral BINOL-based diphosphorimides (i.e. 1-24) were designed. 
By fine-tuning the catalyst structure, highly stereoselective and high yielding synthesis of 
both chiral and non-thermodynamic spiroketals were accomplished. Later, a similar 
strategy was applied to the synthesis of cyclic acetals.35  
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Scheme 1.9 Stereoselective spiroketalization 
At the same time, our group used commercially available TRIP-phosphoric acid 
(S)-1-15 for spiroketalization of sterically encumbered substrates.36 Along with that, 
diastereoselective spirocyclizations of glycals (1-28) were investigated. Remarkably, a 
diastereodifferentiating reaction was observed, and while (S)-1-15 catalyzed formation of 
non-thermodynamic spiroketals, the reactions promoted with (R)-1-15 were completely 
unselective possibly due to matching/mismatching between the chiral catalyst and chiral 
glycals. 
Although conventionally all of the discussed transformations can be generalized as 
oxocarbenium reactions, very few mechanistic studies are available to support the 
intermediacy of well-defined carbocationic species. For the majority of nucleophilic 
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additions discussed in this chapter, more sophisticated concerted mechanisms have been 
proposed. Most importantly, the clear distinction between the mechanistic possibilities 
would potentially allow developing more efficient catalytic systems. Results from our 
group obtained by Grace A. Winshel show that in the case of spiroketalizations, reactions 
proceed through a concerted mechanism without forming an oxocarbenium ion 
intermediate (Scheme 1.10). In this case oxocarbenium species are present only in 
transition state. Additionally, protonation of cyclic deuterated enol ether 1-32 catalyzed by 
chiral phosphoric acid 1-15 results in stereospecific formation of spiroketal 1-33. This 
supports the mechanism proceeding through transition state like 1-31 since such 
mechanisms suggests protonation of the double bond and nucleophilic attack from the same 
face of the molecule. 
Scheme 1.10 Potential reaction mechanisms for spiroketalization reaction 
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Finally, our group recently developed a highly enantioselective heterocyclization 
of α,β-unsaturated acetals 1-34 catalyzed by chiral phosphoric acids (Scheme 1.11). The 
chiral vinyl ether products were shown to undergo enantioenrichment under the prolonged 
reaction conditions. Computational studies that were performed using the growing string 
method with exact transition state search (B3LYP, 6-31G**) showed that the reaction 
proceeds through the formation of mixed chiral phosphate acetal 1-37, followed by SN2’-
like displacement.37 These results oppose the generally accepted formation of vinyl 
oxocarbenium ion.  
Scheme 1.11 Enantioselective aza-Michael reactions 
The discused examples indicate that hydrogen bond donors could serve as excellent 
catalysts for stereocontrolled reactions involving oxocarbenium ions. However, further 
developments in this area would serve to improve the scope of such transformations, 
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develop more efficient and stable catalysts, and gain a deeper understanding of the 
phenomena underlying hydrogen bond and Brønsted acid catalysis.   
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Chapter 2 
Thiophosphoramide-Based Cooperative Catalysts for Brønsted Acid 
Promoted Ionic Diels-Alder Reaction. 
2.1 Introduction 
Over the past several decades, chemists have gathered significant evidence that 
enzymes could drastically accelerate nucleophilic addition reactions by establishing 
mutually reinforcing or cooperative hydrogen bonds within a receptor. These observations 
have inspired the development of various catalytic transformations, in which substrate 
activation is achieved by the formation of multiple hydrogen bonds with a synthetic 
hydrogen bond donor (HBD).1 
The majority of such transformations rely on HBD activation of neutral substrates 
by enhancing their electrophilicity. Recent studies, however, demonstrate that various ionic 
reactions proceeding through polar intermediates could also be catalyzed by HBDs.1b In 
this case, HBD association with the counter anion of an in situ-generated ion pair results 
in enhanced reactivity of the cation (Chapter 1, Section 1.3). Pioneered by Jacobsen2 and 
Schreiner3 groups, counterion activation has been utilized to enhance the reactivity of 
various iminium ions, as well as certain reactions proceeding through the stabilized 
oxocarbenium and carbenium-based ion pairs.4 
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2.2 Gassman Cycloaddition 
Our group is interested in developing organocatalytic transformations involving 
oxocarbenium ions. Particularly interesting to us are reaction of α,β-unsaturated or vinyl 
oxocarbenium ions. Vinyl oxocarbenium ions are allylic cations substituted by at least one 
oxygen atom at one of the terminal carbon atoms. Vinyl oxocarbeniums are typically more 
stable than saturated oxocarbeniums and hence have slightly different chemical behaviour 
compared to saturated oxocarbeniums.  
Scheme 2.1 Reactions of vinyl oxocarbenium ions 
The most common way to generate vinyl oxocarbenium ion intermediates or 
transition states is through protonation of α,β-unsaturated acetals. While vinyl 
oxocarbenium ions produced by activation of α,β-unsaturated acetals can be applied for 
Michael additions, Diels-Alder reactions, [3+4] cycloadditions, etc (Scheme 2.1), 
probably, one of the most known transformations of this type is the ionic [2+4] 
cycloaddition reaction (Gassman cycloaddition). 
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Scheme 2.2 [4+2] cycloaddition of vinyl oxocarbenium ions 
Vinyl oxocarbenium ion participation in Diels-Alder reactions was first mentioned 
in 1982 when Sasaki et. al. reported a reaction between methyl vinyl ketone 2-1 and 
isoprene catalyzed by triethyloxonium tetrafluoroborate to afford Diels-Alder cycloadduct 
2-2 in 72% yield (Scheme 2.2 A).5,6 However, no oxocarbenium ion intermediates were 
observed. Years later Gassman and co-workers showed that acrolein acetals (such as 2-3) 
can be used as vinyl oxocarbenium dienophile precursors when activated by triflic acid 
(Scheme 2.2 B).7 Before this modification of Diels-Alder reaction was developed, α,β-
unsaturated carbonyls were considered to be undesired dienophiles due to their 
participation in many unwanted side reactions such as oxidation and polymerization. α,β-
Unsaturated acetals, on the other hand, are more stable under identical conditions. Thus, 
protection of carbonyl group with an acetal allowed chemists to utilize equivalents of α,β-
unsaturated aldehydes and ketones as dienophiles in [4+2] cycloaddition reaction providing 
high yields for cycloadducts.  
Despite these findings, there were still a number of dienes and dienophiles which 
would not undergo [4+2] cycloaddition or provide very low yields due to polymerization 
or low activity of the reagents. For example, hindered unsaturated acetals, ketals and 
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unreactive dienes typically cause such complications. The Gassman report was followed 
by a large number of publications based on application of vinyl oxocarbenium ions in 
Diels-Alder reactions which showed that both Lewis acids and Brønsted acids can be used 
as catalysts for generation of oxocarbenium ions. However, the only available protocol for 
rate acceleration of Gassman cycloaddition comes from the Grieco group.8 The procedure 
relies on the use of concentrated solution of lithium(I) perchlorate (4.0 M in diethyl ether) 
and catalytic amounts of sulfonic acids. Remarkably, challenging cycloaddition reactions 
could be achieved under these conditions. Thus, by employing Grieco protocol, the 
Danishefsky group has accomplished the formation of cycloadduct 2-7 (Scheme 2.3 A),9 
which is notoriously difficult to obtain by Lewis acid activation of the carbonyl 
functionality-containing dienophiles equivalent to 2-5. Both the presence of lithium(I) 
perchlorate and catalytic sulfonic acid are essential for the progression of this reaction, and 
no reaction occurs if one of these components is omitted. It has been proposed that highly 
ionic medium is essential for the separation of the counterions and the generation of a more 
reactive separated ion pair 2-8.8,10 At the same time, a highly polar medium is important 
for the tighter association of 2-8 and diene 2-6 that results in a decreased transition state 
volume. 
2.3 Thiophosphoramides as co-catalysts 
Despite their synthetic utility, currently existing ionic [4+2] cycloaddition protocols 
have significant limitations since the use of Lewis acids in combination with low reaction 
temperatures or explosive additives such as lithium(I) perchlorate are necessary (Scheme 
2.3 A). This chapter describes our development of a mild organocatalytic protocol that is 
based on the cooperative catalysis of Brønsted acids and HBD co-catalysts.11 Driven by 
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the hypothesis that complexation to a hydrogen bond donor could significantly enhance the 
reactivity of 2-8 by the formation of a more separated ion pair 2-9 (Scheme 2.3 B), we have 
evaluated various HBDs and discovered that catalytic quantities of thiophosphoramide 
2-10 can significantly accelerate the rates of ionic Diels-Alder reactions catalyzed by the 
Brønsted acids. We are not aware of the prior use of the three-hydrogen bond donors such 
as 2-10 for anion-binding activation, and demonstrate that 2-10 is an excellent activator of 
sulfonate anions associated with vinyl oxocarbenium ions. 
Scheme 2.3 Proposed activation of dienophiles in Gassman cycloaddition 
Since sulfonic acids are one of the most common class of Brønsted acids used for 
ionic [4+2] cycloadditions, we wanted to pursue HBDs that are able to accommodate the 
tridentate binding to the sulfonate anion. While most HBDs can provide only up to two 
hydrogen bonds at a time (vide supra), our attention turned to thiophosphortriamides 
(Scheme 2.3 C) which could potentially provide up to three hydrogen bonds at a time. 
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Previous results by the Shea group showed that thiophosphoramide 2-10 is an excellent 
HBD, and can be used as catalysts in Baylis-Hillman and Friedel-Crafts reactions as 
activators of α,β-unsaturated esters and nitroalkenes (Scheme 2.4 A).12 While both 
phosphoramide 2-13 and thiophosphoramide 2-10 showed excellent results, in all cases 
thiophosphoramide 2-10 outperformed 2-13 in catalytic activity. Contemporaneously with 
our studies, Gale and coworkers published NMR titration studies comparing sulfinamide 
2-21, phosphoramide 2-13, and thiophosphoramide 2-10 binding constants to a variety of 
anions.13 These results confirmed that 2-10 can be used as an excellent HBD for our 
purposes. While there have been a few other precedents of anion-binding to three-
hydrogen-bond donors (Scheme 2.4 B),14 thiophosphoramides have a potential of being 
used as chiral hydrogen bond donors for asymmetric reactions15 involving anion activation. 
Scheme 2.4 Three hydrogen bond donors 
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Our studies commenced with the evaluation of various HBD co-catalysts in the p-
TSA-catalyzed ionic Diels-Alder reaction.16 Commercially available acrolein acetal 2-3 
and cyclopentadiene were mixed together with catalytic amounts of p-TSA and HBD 
(Table 2.1) in toluene at –10 ºC. When exposed to p-TSA (3 mol%) without a co-catalyst 
or in combination with thiourea 2-11 (6 mol%), no formation of cycloadduct 2-14 was 
detected after one hour under these conditions (entries 1 and 2). The NH hydrogens of 
squaramide 2-15 are further apart than in thiourea 2-11, and consequently 2-15 is more 
geometrically suited for binding the oxygens of the sulfate anion.17 Indeed, when used as 
a co-catalyst under identical conditions, 2-15 promoted the formation of 2-14 (entry 3), 
albeit in 15% conversion. In the search of alternative HBDs, we turned our attention to 
thiophosphoramides 2-16, 2-17, and 2-10.12,15 We surmised that known thiophosphoramide 
2-10 is geometrically more suited for binding a sulfate anion and could potentially form up 
to three hydrogen bonds with the negatively charged oxygens of sulfate (cf. Scheme 2.3 C 
for an example of such complex).14 Gratifyingly, when used as a co-catalyst, 2-10 
significantly accelerated the reaction of 2-3 and cyclopentadiene, and the quantitative 
formation of cycloadduct 2-14 was detected within one hour (entry 6). In order to test if all 
three NH bonds are essential for the anion activation, thiophosphoramides 2-16 and 2-17 
were evaluated next (entries 4 and 5). Both catalysts were inferior to 2-10 in promoting the 
formation of 2-14 and only minor amounts of the product were observed in each case. A 
control experiment in the absence of p-TSA was conducted (entry 7); however, no 
formation of the product was detected. 
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Table 2.1 Evaluation of hydrogen bond donors under Gassman cycloaddition reaction 
conditions  
The geometry of 2-10 is optimal for forming three hydrogen bonds with 
polyoxygenated tetrahedral anions formed by group III elements (e.g. sulfonates, 
phosphates, perchlorates, etc.). However, even in the situation when there is no clear 
geometrical preference for the anion binding, 2-10 outperformed thiourea 2-11 as the co-
catalyst (Table 2.2). While the acidity of HCl (pKa = 1.8 in DMSO) is close to the acidity 
of sulfonic acids (pKa of MsOH in DMSO is 1.6), a chloride anion could form a tighter ion 
pair with oxocarbenium than sulfonate anions, in which the negative charge is distributed 
among three oxygens. Consistent with this presumption, a significantly longer reaction 
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time (24 h) was required to observe the formation of the product 2-14, and the reaction 
catalyzed by 2-10 proceeded to a higher extend (33%, Table 2.2, entry 3) than the 
corresponding reaction promoted by 2-11 (22%, entry 2). Similar trends were observed for 
the HBr-catalyzed formation of 2-14 (entries 4–6). HBr is stronger than both hydrochloric 
and p-toluenesulfonic acids (pKa = 0.9 in DMSO), and bromide is a weaker coordinating 
anion than chloride. As expected, HBr alone promoted the reaction to a significantly higher 
extent than HCl (37% conversion, 10 h, entry 4). Similarly to the HCl case, the use of 2-10 
as a co-catalyst resulted in an accelerated reaction (97% conversion, 10 h, entry 6). 
Importantly, these experiments indicate that weaker p-toluenesulfonic acid is a more 
effective catalyst than stronger HBr when combined with 2-10 in promoting formation of 
cycloadduct 2-14. We attribute this effect to the higher affinity of 2-10 to the tetrahedral 
sulfate anion due to the geometric predisposition to form three hydrogen bonds with the 
sulfonate oxygens.  Finally, to demonstrate that hydrogen bond donors could accelerate the 
reactions promoted by strong triflic acid, we conducted the experiments described in entries 
7–9 (Table 2.2). Triflic acid alone promoted the formation of 2-14 at –35 ºC; however, this 
reaction was slow and only 20% of 2-14 was observed after 1.5 h.  The addition of the 
thiourea co-catalyst 2-11 did not enhance the cycloaddition; however, 78% conversion was 
observed when 2-10 was employed as the catalyst (entry 9). 
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Table 2.2 Comparison of thiophosphoramide with thiourea in presence of 
different Brønsted acids  
With the optimal reaction conditions in hand, the scope of the ionic [4+2] 
cycloadditions was explored next (Table 2.3). In order to evaluate synthetic utility of this 
protocol, the scope of both dienes (entries 1–4) and dienophiles (entries 5–7) as well as the 
application of this method to the preparation of synthetically useful cis-decaline-based 
building blocks (entries 8–10) has been examined. The reaction of 2-3 with various dienes 
such as cyclopentadiene (entry 1), 2,3-dimethyl-1,3-butadiene (entry 2), 1,3-
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cyclohexadiene (entry 3) and 1,4-dipheny-1,3-butadiene (entry 4) resulted in the formation 
of cycloadducts in good to excellent isolated yields (57-92%) when p-TSA was used in 
combination with thiophosphoramide 2-10. However, neither p-TSA alone nor the 
combination of p-TSA and thiourea 2-11 could promote the formation of cycloadducts to 
a significant extent.  Similarly, the reactions of 5,5-dimethyl-2-vinyl-1,3-dioxane 2-20 
(entry 5), (E)-2-styryl-1,3-dioxolane 2-22 (entry 6) and (E)-2-(prop-1-en-1-yl)-1,3-
dioxolane 2-24 (entry 7) resulted in synthetically useful yields (63–91%) when p-TSA/2-10 
were employed as the catalysts, but failed to result in significant amounts of cycloadducts 
when only p-TSA or the combination of p-TSA and thiourea 2-11 were used as catalysts. 
The ionic [2+4] cycloadditions have found a widespread application in the 
synthesis of highly functionalized decalines (vide supra).  To demonstrate that our protocol 
is amenable to the synthesis of these valuable building blocks, the reactions of 2-
cyclohexenone and 2-methyl-2-cyclohexenone-derived dioxolanes (2-26 and 2-28 
respectively) were tested (entries 8 and 9). While the cycloadditions were found to be slow 
in toluene, the use of dichloromethane as the solvent and increased catalyst loadings (5 
mol% of p-TSA, 10 mol% of 2-10) lead to the formation of the corresponding cycloadducts 
in good yields (68% and 84% correspondingly). 
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Table 2.3 The scope of organocatalytic ionic [4+2] cycloaddition  
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Table 2.3 (continued) The scope of organocatalytic ionic [4+2] cycloaddition  
Finally, to test whether this method is applicable to the challenging cycloadditions 
the reaction of 2-(cyclohex-1-en-1-yl)-1,3-dioxolane 2-5 and 2,3-dimethyl-1,3-butadiene 
was executed (Table 2.3, entry 10). The Lewis acid-catalyzed reactions of cyclohex-1-
enecarbaldehyde or cyclohex-1-enecarboxylates are notoriously difficult to execute with 
unactivated dienes (vide infra), while the Grieco protocol could be used to provide the 
analogous cycloadduct 2-7 in 53% yield (Scheme 2.3).9 Remarkably, co-catalyst 2-10 in 
combination with p-TSA was sufficient to promote the formation of the corresponding 
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cycloadduct 2-30 in 59% yield (Table 2.3, entry 10) without resorting to the use of a highly 
ionic medium (4 M solution of lithium(I) perchlorate in diethyl ether). 
2.4 Tosylate/thiophosphoramide complexation studies 
To confirm that 2-10 complexes anions and to gain a better understanding of the 
observed effect, binding and computational studies have been conducted. First, the 
association of 2-10 with sulfonate anions was confirmed by Pui-In Tang by combining 
2-10 with known methylpyridinium tosylate (2-31) at different proportions and observing 
the resulting 1H NMRs (Figure 2.1). Thus, the addition of 2-31 to solution of 2-10 resulted 
in a concentration-dependent shift of the phosphoramide NH protons downfield, which is 
characteristic of hydrogen bonding to anion.18 WinEQNMR19 was used to establish the 
association constant of this complex (Ka = 7.3•104 in CDCl3). Based on the value of Ka, we 
conclude that 2-10 strongly binds tosylate anion of 2-31 in chloroform. 
The stoichiometry of the resultant complex between 2-31 and 2-10 was determined 
by 1H NMR titration using continuous variation method (Job plot, see Experimental 
Section).20 The stoichiometry of binding is consistent with the formation of 1:1 complex 
between 2-31 and 2-10. Our further attempts to compare the association constant value of 
2-31 and 2-10 with the corresponding Ka’s of 2-11/Ts– or 2-10/Cl– did not result in 
conclusive results due to the more complex stoichiometries of the resultant supramolecular 
complexes. 
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 Figure 2.1 Titration studies 
In addition to NMR studies, the complex between 2-10 and 2-31 was crystallized 
and the structure was analyzed using single crystal X-ray diffraction (Figure 2.2). 
Interestingly, 2-10 does form three hydrogen bonds with the tosylate anion, however the 
geometry of 2-10 in solid state precludes the formation of a tetrahedral structure (Scheme 
2.3). In the solid state tosylate anion forms hydrogen bonds with two thiophosphoramide 
molecules, while thiophosphoramide provides three hydrogen bonds to two tosylates. 
Thus, the single crystal has a polymer-like structure based on hydrogen bonds. Bond 
distances were measured between nitrogens of 2-10 and oxygens of tosylate and were 
9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 PPM
0.025 mM
0 mM
0.096 mM
0.227 mM
0.451 mM
0.788 mM
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found to be 2.779 Å (single H-bond), 2.826 Å an 2.998 Å (two H-bonds). While the X-ray 
structure shows that one thiophosphoramide molecule cannot form three hydrogen bonds 
with a tosylate, the possibility of forming such a complex in solution cannot be ruled out.  
Figure 2.2 X-ray structure of 2-10•2-31 
Finally, computational studies were initiated to model the interactions of the 
sulfonate and 2-10 (Figure 2.3). Thus, DFT-based geometry optimization of 2-10 and 
mesylate (B3LYP, 6-31+G*, toluene) resulted in a complex, in which three NH hydrogens 
of 2-10 are bound to all three oxygens of the mesylate anion. This complex was found to 
be by 3.7 kcal/mol more stable than the corresponding complex of thiourea 2-11. While 
these results support the proposal that 2-10 is the most effective co-catalyst due to its 
stronger association with anions, which consequently result in more activated vinyl 
oxocarbenium ion, a more complex mechanistic scheme is likely to be operational. 
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Figure 2.3 Computed complex between 2-10 and mesylate 
 The proposed mechanism of the ionic Diels-Alder transformation catalyzed with p-
toluenesulfonic acid and thiophosphoramide 2-10 is depicted in Scheme 2.5. It is not clear 
however if the acidic species that participate in protonation of an acetal is pTSA or its 
complex with 2-10. 
Scheme 2.5 Proposed mechanism for the ionic Diels-Alder reaction 
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2.5 Conclusions 
In conclusion, the combination of a Brønsted acid as the catalyst and a hydrogen 
bond donor as the co-catalyst can be used to catalyze a variety of ionic [2+4] cycloaddition 
reactions under mild conditions that do not require the use of a highly ionic medium (e.g. 
4 M lithium(I) perchlorate in ether). Remarkably, thiophosphoramide 2-10, which has not 
been previously utilized for the anion binding was found to be superior to the standard two 
hydrogen bond donors such as thiourea 2-11 or squaramide 2-15. Computational, X-ray, 
and NMR studies suggest that this could be attributed to the ability of 2-10 to form strong 
three hydrogen-bond-containing complexes with the anions. This effect was found to be 
especially strong for sulfonate anions, the geometry of which favors the formation of three 
hydrogen bonds with the sulfonate oxygens. Recent results from the Kozlowski group show 
that thiophosphoramide 2-10 is one of the strongest neutral small molecule hydrogen bond 
donors available and used in organocatalysis.21 
2.6 Experimental 
Unless otherwise stated, all reagents were purchased from commercial suppliers 
and used without purification. Toluene (PhMe), dichloromethane (CH2Cl2) and diethyl 
ether (Et2O) were filtered through a column (Innovative Technology PS-MD-5) of 
activated alumina under nitrogen atmosphere. All reactions were carried out under an 
atmosphere of nitrogen in flame- or oven-dried glassware with magnetic stirring. Reactions 
were cooled via external cooling baths: ice water (0 °C), Neslab Cryotrol CB-80 immersion 
cooler (0 to -60 °C) or Neslab Cryocool immersion cooler CC-100 II. Purification of the 
reactions mixtures was performed by flash chromatography using SiliCycleSiliaFlash P60 
(230-400 mesh) silica gel. All spectra were recorded on Varian vnmrs 700 (700 MHz), 
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Varian vnmrs 500 (500 MHz), Varian MR400 (400 MHz), Varian Inova 500 (500 MHz) 
spectrometers and chemical shifts (δ) are reported in parts per million (ppm) and referenced 
to the 1H signal of the internal tetramethylsilane according to IUPAC recommendations.22 
Data are reported as (br = broad, s = singlet, d = doublet, t = triplet, q = quartet, qn = quintet, 
sext = sextet, m = multiplet; coupling constant(s) in Hz; integration). High resolution mass 
spectra (HRMS) were recorded on MicromassAutoSpecUltima or VG (Micromass) 70-
250-S Magnetic sector mass spectrometers in the University of Michigan mass 
spectrometry laboratory. Infrared (IR) spectra were recorded as thin films on NaCl plates 
on a Perkin Elmer Spectrum BX FT-IR spectrometer. Absorption peaks were reported in 
wavenumbers (cm-1). All commercially unavailable acetals and ketals were prepared 
following the procedure reported by Lu and coworkers.23 Commercially unavailable 
hydrogen bond donors were synthesized by previously reported procedures.24  
 
Synthesis of thiophosphoramide 2-16. 
Phenol (1.11 g, 11.8 mmol) and triethylamine (1.81 mL, 18.9 mmol) were added to 
a flame-dried 200mL round bottom flask charged with 30 mL dry dichloromethane. Flask 
was cooled to 0 °C and thiophosphoryl chloride (0.60 mL, 5.9 mmol) was added dropwise. 
After two hours TLC indicated reaction went to completion. Solvent was evaporated and 
1H NMR confirmed desired diphenoxythiophosphoryl chloride. Compound was used 
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directly in the following reaction without purification. 1H NMR (400 MHz, CDCl3): δ = 
7.44 (t, J = 7.6 Hz, 2 H), 7.37-7.27 (m, 3 H).25  
Previously made diphenoxythiophosphoryl chloride (285 mg, 1 mmol) was 
dissolved in 3 mL of dry acetonitrile. 4-Dimethylaminopyridine (244.3 mg, 2 mmol) was 
then added followed by triethylamine (0.98 mL, 7 mmol), and 3,5-
bis(trifluoromehtyl)aniline (313 µL, 2 mmol) at room temperature. The mixture was 
refluxed for 48 hours. Reaction was then quenched with saturated NaHCO3. The product 
was extracted with diethyl ether, and then organic layer was dried over MgSO4, filtered 
and concentrated in vacuo. Crude product was purfied by column chromatography (3:1 
hexanes/ethyl acetate) and all fractions with product, including those with impurities were 
collected. Product was recrystallized from hexanes. 
White solid, 62% yield (592 mg). IR (thin film, cm-1): 3246, 1717, 1621, 1490, 
1471, 1391, 1276, 1183, 1136, 986, 927, 794, 686. 1H NMR (400 MHz, CDCl3): δ 7.66 (s, 
2H), 7.58 (s, 1H), 7.36 (t, J = 7.7 Hz, 4H), 7.24 (t, J = 7.7 Hz, 2H), 7.18 (d, J = 7.7 Hz, 
4H), 6.01 (d, J = 15.0 Hz, 1H); 13C NMR (175 MHz, CDCl3): δ 150.1 (2C), 140.5, 133.0 
(q, J = 34 Hz, 2C), 129.8, 126.0, 123.7, 122.2, 121.0 (2C), 117.9, 116.2,  31P NMR (162 
MHz, CDCl3) δ 55.0 (s); 19F NMR (376 MHz, CDCl3) δ -63.1 (s); HRMS (ESI+) (m/z): 
[M+H]+ calcd for C20H15F6NO2PS 478.0453, found 478.0460. 
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Synthesis of thiophosphoramide 2-17. 
Phenol (277.6 mg, 2.95 mmol) and triethylamine (0.50 mL, 3.54 mmol) were added 
to a flame-dried 200mL round bottom flask charged with 30 mL dry dichloromethane. The 
mixture was cooled to 0 °C and thiophosphoryl chloride (0.30 mL, 2.95 mmol) was added 
dropwise. After two hours TLC indicated reaction went to completion. Solvent was 
evaporated and 1H NMR confirmed desired phenoxythiophosphoryl chloride. Compound 
used directly in following reaction without purification. 1H NMR (400 MHz, CDCl3): δ = 
7.44 (t, J= 7.6 Hz, 2 H), 7.315 (m, 3 H).3  
Phenoxythiophosphoryl chloride, together with 4-dimethylaminopyridine (1.194 g, 
11.8 mmol) were added to a 200mL round bottom flask followed by triethylamine (15 mL, 
88.5 mmol) and 3,5-bis(trifluoromehtyl)aniline (2.7 g, 11.8 mmol). The mixture was 
refluxed for 48 hours. Reaction was then quenched saturated NaHCO3. Products were 
extracted with diethyl ether. Organic layer was then dried over MgSO4, filtered and 
concentrated. The product was purfied by column chromatography using gradient from 5% 
to 20% dichloromethane in hexanes). All fractions with product, including those with 
impurities were collected. Product was then recrystallized from hexanes.  
White solid, 40% yield (713 mg after 2 recrystallizations). IR (thin film, cm-1): 
3414, 3239, 1622, 1592, 1491, 1471, 1388, 1279, 1188, 1133, 1004, 979, 928, 896, 683. 
1H NMR (700 MHz, CDCl3): δ= 7.56 (s, 4H), 7.55 (s, 2H), 7.39 (t, J = 7.8 Hz, 2H), 7.28 
(t, J = 7.6 Hz, 1H), 7.16 (d, J = 7.9 Hz, 2H), 5.84 (d, J = 10.5 Hz, 2H); 13C NMR (175 
MHz, CDCl3) 149.1 (2C), 139.8, 133.0 (q, J = 33.7 Hz, 6C), 130.1, 126.4, 125.1, 123.6, 
122.0, 121.2 (2C), 118.5, 116.8; 31P NMR (283 MHz, CDCl3) δ 51.2 (s); 19F NMR (376 
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MHz, CDCl3) δ -63.2 (s); HRMS (ESI+) (m/z): [M+H]+ calcd for C22H14F12N2OPS 
613.0367, found 613.0361. 
Synthetic procedures and characterization data for the cycloadducts from Table 2. 
The cycloadducts 2-14,26 2-18,27 2-4,28 2-21,29 2-23,25 2-2530 have been previously 
characterized. The characterization data for compounds 2-19, 2-27, 2-29, and 2-30 is 
provided below. 
General procedure for catalyst screening, Table 2.1. 
Reactions were run on 0.5-0.7 mmol scale based on dienophile. An oven-dried 4-
mL scintillation vial was charged with anthracene, 3 mol% pTSA and 6 mol% HBD. The 
vial was then flushed with nitrogen. Dry solvent (toluene or diethyl ether) was added to 
ensure 0.3 M concentration of 2-vinyl-1,3-dioxolane. The reaction mixture was brought to 
-78 oC and then 2-vinyl-1,3-dioxolane (1 equiv, 0.5 mmol) and cyclopentadiene (3 equiv, 
1.5 mmol) were added via micro syringe. The resulting mixtrure was stirred at the 
temperature indicated in Table 1 for the indicated time. The reaction was quenched with 
approximately 6 mol% of triethylamine. The conversions were determined using the 
following formula: conversion (%) = 100% - (yield (starting material, %). Yield of the 
starting material (%) = 100% • [ν(starting material) / ν(standard)] • n, where 
ν(product) / ν(standard) is the integral ratio of the corresponding 1H NMR peaks and n is 
the ratio of the standard to the initial amount of starting material (in mol). 
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General procedure A for Diels-Alder reactions catalyzed by pTSA or pTSA/2-11, 
Table 2.3 (entries 1–3, 6, 7) 
Reactions were run on 0.5-0.9 mmol scale based on dienophile. An oven-dried 4-
mL scintillation vial was charged with anthracene, 3 mol% pTSA and 6 mol% catalyst 
2-11. The vial was then flushed with nitrogen. Dry toluene was added to ensure 0.3 M 
concentration of a dienophile. The reaction mixture was brought to 0 oC and then 
dienophile (1 equiv) and diene (5 equiv) were added via micro syringe. The resulting 
mixtrure was stirred at 0 oC for the time indicated in Table 2. The reaction was quenched 
with approximately 6 mol% of triethylamine. The 1H NMR yields were calculated using 
the following formula: yield (%) = 100% • [ν(product) / ν(standard)] • n, where 
ν(product)) / ν(standard) is the integral ratio of the corresponding 1H NMR peaks and n is 
the ratio of the standard to starting material (in mol). 
General procedure B for Diels-Alder reactions catalyzed by pTSA/2-10, Table 2.3 
(entries 1–3, 6, 7) 
Reactions were run on 0.5-0.9 mmol scale based on dienophile. An oven-dried 4-
mL scintillation vial was charged with 3 mol% pTSA and 6 mol% catalyst 2-10. The vial 
was then flushed with nitrogen. Dry toluene was added to ensure 0.3 M concentration of a 
dienophile. The reaction mixture was brought to 0 oC and then dienophile (1 equiv) and 
diene (5 equiv) were added via micro syringe. The resulting mixtrure was stirred at 0 oC 
for the time indicated in Table 2. The reaction was quenched with approximately 6 mol% 
of triethylamine. The mixture was directly subjected to column chromatography. Elution 
with hexanes allowed removal of excess toluene and diene. Subsequent purification of the 
cycloadduct was performed using 20:1 hexanes/diethyl ether. 
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General procedure C for Diels-Alder reactions catalyzed by pTSA or pTSA/2-11, 
Table 2.3 (entries 5, 8–10) 
Reactions were run on 0.3-0.7 mmol scale based on dienophile. An oven-dried 4-
mL scintillation vial was charged with anthracene, 5 mol% pTSA and 10 mol% catalyst 
2-11. The vial was then flushed with nitrogen. Dry dichloromethane was added to ensure 
0.6 M concentration of a dienophile. The reaction mixture was brought to 0 oC and then 
dienophile (1 equiv) and diene (5 equiv) were added via micro syringe. The resulting 
mixtrure was stirred at the temperature indicated in Table 2 for the indicated time. The 
reaction was quenched with approximately 10 mol% of triethylamine. The 1H NMR yields 
were calculated using the following formula: yield (%) = 100% • [ν(product) / ν(standard)] 
• n, where ν(product) / ν(standard) is the integral ratio of the corresponding 1H NMR peaks 
and n is the ratio of the standard to starting material (in mol). 
General procedure D for Diels-Alder reactions catalyzed by pTSA/2-10, Table 2.3 
(entries 5, 8–10) 
Reactions were run on 0.3-0.7 mmol scale based on dienophile. An oven-dried 4-
mL scintillation vial was charged with 5 mol% pTSA and 10 mol% catalyst 2-10. The vial 
was then flushed with nitrogen. Dry dichloromethane was added to ensure 0.6 M 
concentration of dienophile. The reaction mixture was brought to 0 oC and then dienophile 
(1 equiv) and diene (5 equiv) were added via micro syringe. The resulting mixtrure was 
stirred at the temperature indicated in Table 2 for the indicated time. The reaction was 
quenched with approximately 10 mol% of triethylamine. Volatiles were evaporated in 
vacuo and then the mixture was subjected to column chromatography using 20:1 
hexanes/diethyl ether. 
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Synthesis of 2-(1',2',3',4'-tetrahydro-[1,1':4',1''-terphenyl]-2'-yl)-1,3-
dioxolane (2-19, Entry 4) 
An oven-dried 4-mL scintillation vial was charged with 5 mol% (3.6 mg, 
0.0209 mmol) pTSA and 10 mol% (31.2 mg, 0.0418 mmol) catalyst 2-10. 
The vial was then flushed with nitrogen. In a separate vial a 0.9 M solution of 259 mg (1.25 
mmol) (1E,3E)-1,4-diphenylbuta-1,3-diene (3 equiv) in dry dichloromethane was made 
and added to the mixture of catalysts. Then 41.8 μL (0.418 mmol) of 2-vinyl-1,3-dioxolane 
(1 equiv) and was added via micro syringe. The resulting mixtrure was stirred at room 
temperature for 5 h. The reaction was quenched with approximately 10 mol% of 
triethylamine. Volatiles were evaporated in vacuo and then the mixture was subjected to 
column chromatography using 1:1 hexanes/toluene. Reactions catalyzed by pTSA or 
pTSA/7a were analyzed by crude 1H NMR using anthracene as an internal standard. 
Colorless oil, 62% yield, 8.3:1 endo/exo; IR (thin film, cm-1) 3024, 2950, 2883, 
1600, 1491, 1451, 1414, 1311, 1156, 1079, 1032, 957, 925, 857, 758, 701. Endo product: 
1H NMR (400 MHz, CDCl3) δ 7.44 (d, J = 7.6 Hz, 2H), 7.39-7.33 (m, 4H), 7.33-7.28 (m, 
2H), 7.27-7.19 (m, 2H), 6.02 (d, J = 10.1 Hz), 5.89 (ddd, J = 10.1, 2.7, 2.4 Hz, 1H), 4.07 
(d, J = 8.4 Hz, 1H), 4.00-3.87 (m, 2H), 3.85-3.76 (m, 2H), 3.72-3.66 (m, 1H), 3.63-3.53 
(m, 1H), 2.22 (dddd, J = 13.2, 8.1, 5.5, 2.4 Hz, 1H), 2.01 (dd, J = 12.9, 5.5 Hz, 1H), 1.56 
(q, J = 12.9 Hz, 1H). Distinct peaks for exo product: 1H NMR (400 MHz, CDCl3) δ 4.81 
(d, J = 3.6 Hz, 1H), 1.83 (dd, J = 10.5, 6.6 Hz, 1H); Endo only: 13C NMR (101 MHz, 
CDCl3) δ 145.3, 138.1, 135.4, 128.4, 128.1, 125.8, 106.8, 67.1, 51.5, 49.4, 47.0, 46.7, 44.3, 
26.0; HRMS (ESI+) (m/z): [M+NH4]
+ calcd for C17H24NO2 274.1802; found 274.1800. 
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6,7-Dimethyl-3,4,4a,5,8,8a-hexahydro-2H-spiro[naphthalene-1,2'-
[1,3]dioxolane] (2-27, Entry 8) 
Colorless oil, 68% yield. IR (thin film, cm-1) 2927, 2829, 1717, 1441, 
1377, 1354, 1298, 1160, 1098, 1087, 1050, 940, 876, 771. 1H NMR (400 
MHz, CDCl3) δ 3.98-3.87 (m, 4H), 2.25 (d, J = 16.8 Hz, 1H), 2.05-1.85 (m, 4H), 1.79-1.63 
(m, 4H), 1.59 (br s, 6H), 1.54-1.47 (m, 1H), 1.37-1.17 (m, 2H). 13C NMR (175 MHz, 
CDCl3) δ 123.5, 122.6, 64.1, 40.9, 37.9, 32.9, 29.8, 29.6, 26.0, 23.2, 19.1, 18.9. HRMS 
(EI) (m/z): [M]+ calcd for C14H22O2 222.1620, found 222.1621. 
6’,7’,8a’-trimethyl-3’,4’,4a’,5’,8’,8a’-hexahydro-2’H-spiro[[1,3]-
dioxolane-2,1’-naphthalene] (2-29, Entry 9) 
Pale yellow oil, 84% yield. : IR (thin film, cm-1)  2927, 1448, 1368, 1172, 
1085, 950. 1H NMR (700 MHz, CDCl3) δ 3.98-3.92 (m, 4H), 2.27 (d, J = 
18.2 Hz, 1H), 2.22 (d, J = 18.2 Hz, 1H), 1.73 (td, J = 13.3, 4.6 Hz, 1H), 1.68-1.60 (m, 3H), 
1.59 (s, 6H), 1.57-1.52 (m, 3H), 1.49 (qt, J = 13.3, 4.3 Hz, 1H), 1.29 (qd, J = 13.3, 3.8 Hz, 
1H), 1.27-1.22 (m, 1H), 0.97-0.87 (m, 1H), 0.85-0.76 (m, 1H); 13C NMR (175 MHz, 
CDCl3) δ 122.0, 121.9, 112.9, 65.0, 64.8, 41.3, 38.3, 36.2, 35.7, 30.3, 28.4, 22.8, 19.2, 19.0, 
18.2. HRMS (ES+) (m/z): [M+H]+ calcd for C15H24O2 237.1849, found 237.1841.  
6,7-Dimethyl-1,3,4,5,8,8a-hexahydronaphthalen-4a(2H)-yl)-
1,3-dioxolane (2-30, Entry 10) 
Colorless oil, 59% yield. IR (thin film, cm-1) 2923, 2861, 1704, 1453, 
1394, 1351, 1165, 1137, 1121, 1084, 1066, 955, 856. 1H NMR (700 MHz, 
CDCl3) δ 4.87 (s, 1H), 3.95-3.90 (m, 1H), 3.89-3.79 (m, 3H), 2.35 (d, J = 18.3 Hz, 1H), 
2.19 (d, J = 18.3, 1H), 1.78-1.72 (m, 2H), 1.66-1.61 (m, 1H), 1.60 (s, 3H), 1.58 (s, 3H), 
1.56-1.51 (m, 2H), 1.45-1.37 (m, 2H), 1.34-1.27 (m, 3H), 1.26-1.18 (m, 1H). 13C NMR 
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(175 MHz, CDCl3) δ 123.0, 121.8, 106.2, 65.3, 64.9, 39.2, 36.2, 34.9, 32.6, 29.2, 26.7, 
25.8, 21.5, 19.0, 18.9. HRMS (EI) (m/z): [M]+ calcd for C15H24O2 236.1776, found 
236.1776. 
1H NMR continuous variation method (Job plot) 
Stock solutions of N-methylpyridinium tosylate and thiophosphoramide in CDCl3, 
both having a concentration of 5 mM, were prepared. Aliquots of each solution were mixed 
in several 5 mm NMR tubes such that the total volume in each tube was 1.0 mL and the 
mole fraction of catalyst was varied from 0.1 to 1.0 M across 10 samples. 1H NMR spectra 
were collected on a 500 MHz instrument at 25°C. The chemical shift of the amide proton 
of the catalyst (δobs) was noted in each sample and a Job plot was created by plotting (δobs- 
δfree) • [catalyst]0 against the mole fraction of the catalyst, where [catalyst]0 is the initial 
concentration of catalyst measured into each sample. The plot thus obtained showed a 
maxima at a mole fraction of 0.5, suggesting a 1:1 binding stoichiometry in the tosylate-
thiophosphoramide complex.  
N-H peak shift 
Mole fraction δobs δobs - δfree [Phosph]0 (δobs - δfree) • [Phosph]0 
0.1 8.1506 2.3925 0.0005 0.00119625 
0.2 8.1448 2.3867 0.001 0.0023867 
0.3 8.135 2.3769 0.0015 0.00356535 
0.4 8.115 2.3569 0.002 0.0047138 
0.5 8.0756 2.3175 0.0025 0.00579375 
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0.6 7.5603 1.8022 0.003 0.0054066 
0.7 6.8571 1.099 0.0035 0.0038465 
0.8 6.4503 0.6922 0.004 0.0027688 
0.9 6.1046 0.3465 0.0045 0.00155925 
1 5.7581 0 0.005 0 
 
1H NMR titrations 
A 0.5 mM solution of thiophosphoramide in CDCl3 was prepared, of which 500 μL 
was placed in a 5 mm NMR tube. A 2.5 mM solution of N-methylpyridinium tosylate in 
CDCl3 containing 0.5 mM thiophosphoramide 2-10 was prepared as the titrant. Aliquots 
of 5 – 10 μL of the second solution were sequentially added to the NMR tube and the 1H 
NMR spectrum was collected after each addition on a 500 MHz instrument at 25°C. The 
chemical shift of the amide proton of the catalyst was noted in each sample. The binding 
constant was then calculated using the WinEQNMR program.31 Three titrations were thus 
performed to furnish an averaged binding constant (Ka = 7.3•104).  
Job Plot
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Chapter 3 
Chiral Brønsted Acid-Catalyzed Enantioselective Ionic [4+2] 
Cycloadditions 
3.1 Introduction 
While designing a catalyst capable of controlling the reactivity of an oxocarbenium 
ion still represents a formidable challenge, the use of chiral catalysts to control 
enantioselective reactions of oxocarbenium ions is well precedented.1 In particular, several 
reports, describing chiral phosphoric acid-catalyzed reactions presumably proceeding 
through enantioselective nucleophilic addition to oxocarbenium ions, have appeared over 
the past three years.2,3 Although the precise nature of the catalytic mechanisms and 
intermediates in such transformations is yet to be clarified,3 the existence of 
oxocarbenium/chiral phosphate ion pair has been invoked. The chirality of a chiral 
counterion could, in theory, control not only the direct addition of nucleophiles to 
oxocarbenium ions, but also reactions at the remote sites. Thus, we surmised that the 
protonation of an α,β-unsaturated acetal with a chiral Brønsted acid or a combination of 
chiral HBD and achiral Brønsted acid would result in the formation of a vinyl 
oxocarbenium/chiral counterion pair 3-2 (Scheme 3.1 A), and that the olefinic portion of 
the resultant ion pair 3-2 could undergo various counterion-directed enantioselective 
reactions. Our group has obtained experimental evidence confirming the feasibility of such 
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counterion directed reactions. This chapter summarizes our studies in this vein and 
provides the first successful example of a catalytic enantioselective Gassman cycloaddition 
reaction of α,β-unsaturated acetals and dienes catalyzed by N-triflylphosphoramides. 
Scheme 3.1 Stereoselective ionic Diels-Alder reactions 
While Gassman cycloaddition is a popular protocol for ionic [4+2] cycloadditions 
and a variety of Lewis and Brønsted acids are used for activation of α,β-unsaturated 
acetals,4 no catalyst-controlled enantioselective Gassman cycloaddition was known. The 
only asymmetric cycloaddition was developed by the Sammakia group.5 The method is 
based on the use of chiral acetals derived from 2,4-pentanediol (3-4, Scheme 3.1 B). While 
diastereoselectivity of up to 15:1 was observed when the reaction was catalyzed by a TiCl4 
– Ti(OiPr)4 mixture, the substrate scope was rather limited. Subsequent publications by 
other groups broadened the scope of the reaction and further optimized the reaction 
conditions.4 
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3.2 Enantioselective Cycloaddition 
Our studies commenced with the attempts to identify an appropriate Brønsted acid 
catalyst that is capable of promoting a cycloaddition reaction between α,β-unsaturated 
acetal 3-6 and cyclopentadiene (Table 3.1). Representative Brønsted acids 3-8 – 3-11 were 
combined with dioxolane 3-6 and cyclopentadiene (2 equiv) in acetonitrile (entries 1–4) 
and toluene (entries 5–8), and the formation of 3-7 was monitored by GC-MS. While all of 
the catalysts promoted the formation of cycloadduct 3-7 in acetonitrile, only N-
triflylphosphoramide 3-11 catalyzed the cycloaddtion in toluene (16 h, 65%, 44:56 e.r.). In 
addition, the reactions catalyzed by 3-9 and 3-11 were evaluated in dioxane (entires 9 and 
10). While N-triflylphosphoramide 3-11 catalyzed the formation of 3-7 (16 h, 80% yield), 
phosphoric acid 3-9 did not promote any cycloaddition. 
The observed solvent effect could be attributed to the higher reactivity of the ion 
pair 3-2 in acetonitrile due to the better solvation of the intermediate oxocarbenium ion. 
Insignificant stereoinduction is expected for the solvated ion pairs, which is consistent with 
the observation that the reactions catalyzed by 3-9 and 3-11 in acetonitrile produced 
racemic products (entries 2 and 4). The higher catalytic activity of 3-11 in toluene and 
dioxane could be attributed to a higher acidity of this compound relative to the other 
catalysts6 as well as to a lower coordinating ability of the resultant anion. A stronger 
Brønsted acid is expected to populate larger quantities of the oxocarbenium ion, while an 
ion pair (3-2) with a less coordinating anion will be more reactive due to the lower energy 
of the LUMO. 
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Table 3.1 Preliminary catalyst and solvent screening 
Based on the unique ability of 3-11 to catalyze the IDA of 3-6 and cyclopentadiene 
in various solvents, the evaluation of various N-sulfonylphosphoramides 3-12 – 3-19 in 
toluene was executed next (Table 3.2). The variation of the aromatic substituents (Ar) on 
the BINOL backbone of the catalyst (entries 2–4) helped to identify 3-14 (Ar = 2,4,6-(i-
Pr)3C6H2) as the catalyst of choice (entry 4). Thus, the formation of 3-7 proceeded with 
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improved yield (75%) and selectivities (64:36 e.r., 5:1 d.r.) when compared to the catalysts 
3-11 – 3-13. To further improve the conversion for this reaction, more acidic N-
triflylthiophosphoramide 3-15 was utilized as a catalyst (entry 5). Although the 
enantioselectivity and d.r. for those reactions were similar to the corresponding selectivities 
observed for 3-14, the product yield for the reaction catalyzed by catalyst 3-15 was found 
to be significantly lower (24%). Probably, the diminished activity of 3-15 results from the 
lower reactivity of the ion pair 3-2 due to the stronger coordination of the N-
triflylthiophosphoramide anion derived from 3-15 to the oxocarbenium ion. In an attempt 
to affect the coordinating properties of the N-sulfonylphosphoramide counterion, we 
decided to evaluate the effect of the N-triflyl group on the cycloaddition rate and selectivity. 
Thus N-mesylphosphoramide 3-16 (entry 6) and N-pentafluorophenyl-
sulfonylphosphoramide 3-17 (entry 7) were synthesized and screened. However, neither 
3-16 nor 3-17 were found to promote the IDA reaction leading to 3-7. This is likely to 
result from the significantly lower acidities of 3-16 and 3-17 in comparison with N-
triflylphosphoramides (for example, the pKas of CH3SO2NH2 and CF3SO2NH2 in DMSO 
are 17.5, and 9.7, respectively).7 Finally, our attempts to evaluate H8-BINOL and VAPOL-
based N-triflylphosphoramides 3-18 and 3-19 did not result in improved reactivities or 
selectivities (entries 8 and 9). While both 3-18 and 3-19 could promote the formation of 
the cycloadduct 3-7, the selectivities of these reactions were significantly lower than for 
the BINOL-derived N-sulfonylphosphoramides 3-12 – 3-17. 
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Table 3.2 Evaluation of various N-triflylphosphoramides  
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With the optimal catalyst (3-14) identified, the effect of the solvent on the formation 
of 3-7 was determined next to optimize the enantioselectivity of the cycloaddition (Table 
3.3). Consistent, with the results obtained in acetonitrile, the formation of 3-7 in 
isopropanol was completely unselective (entry 1). Reducing the polarity of the solvents 
significantly improved the enantioselectivity and diastereoselectivity of the cycloaddition 
(entries 2–8). Remarkably, the reaction in weakly coordinating ethyl acetate (entry 8) was 
the most selective (73: 27 e.r., 7:1 d.r.). Employing other ester-containing solvents such as 
methyl pivalate (entry 9) and ethyl isobutyrate (entry 10) resulted in increased selectivities. 
Thus, the cycloaddition of 3-6 and cyclopentadiene in ethyl isobutyrate as the solvent 
resulted in enantio- and diastereoenriched 3-7 (80:20 e.r., 7:1 d.r.). It is noteworthy that the 
reactions utilizing other catalysts were also more selective when ethyl isobutyrate was 
employed as the solvent (entries 11–14). However, catalyst 3-14 was still found to be 
superior in terms of enantio- and diastereocontrol. 
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Table 3.3 Evaluation of the solvent effect on ionic Diels-Alder stereoselectivity 
The scope and limitation of the catalytic asymmetric ionic cycloaddition was 
evaluated next (Table 3.4). As the changes in the acetal portion of the dienophile could 
significantly affect the reaction rates and selectivities, substrates 3-20a – 3-20c were 
synthesized and subjected to cycloaddition with cyclopentadiene (entries 2–4). The 
hydrolysis of unsaturated 1,3-dioxanes such as 3-20a is known to progress faster than the 
hydrolysis of the corresponding dioxolanes.8 However, the oxocarbenium ion resulting 
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from 1,3-dioxane 3-20a was found to be a less reactive dienophile than 3-6 although both 
reactions proceeded with the similar levels of stereocontrol. The introduction of the 
additional gem-dimethyl substitution to the acetal backbone of 1,3-dioxane (3-20b, entry 
3) resulted in significant reduction of the reactivity and no reaction was observed for 3-20b. 
This observation is consistent with the experimental results obtained for the hydrolysis of 
gem-dimethyl substituted vinyl 1,3-dioxanes and could result from the both steric and 
stereoelectronic effects.8 Finally, the reaction of cinnamaldehyde dimethyl acetal (3-20c) 
with cyclopentadiene resulted in the formation of the corresponding product (68:32 e.r., 
8:1 d.r.). Consistent with the observations made by Gassman, the cycloadduct yield for the 
reaction with 3-20c was significantly lower than the corresponding yield with the cyclic 
acetal 3-6. This could be ascribed to the higher reactivity of the intermediate oxocarbenium 
ion that undergoes competitive oligomerization. The possibility of utilizing ketone-derived 
dioxolane 3-20d was examined next (entry 5). Although the ionization of 3-20d should 
provide a significantly more stable oxocarbenium ion in comparison to the corresponding 
ionization of 3-6, the reaction of 3-20d was significantly slower albeit selective (29% yield, 
70:30 e.r., endo isomer). In addition, significant amounts of the hydrolyzed starting 
material and products were also observed. To delineate the role of the C3 substitution, 
acetal 3-20e was synthesized and evaluated (entry 6). Although the replacement of the 
phenyl substituent with the cyclohexyl should result in a less labile acetal, the reactivity of 
3-20e was not significantly different from 3-6 (60% yield, 4:1 d.r.). 
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Table 3.4 Substrate scope  
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The acrolein-derived acetals 3-20f – 3-20h were significantly more reactive (entries 
7–9). Thus, the reaction with vinyl dioxolane provided corresponding cycloadduct 3-21f 
even at –20 ºC (52% yield, 77:23 e.r., 3:1 d.r.). While the cinnamaldehyde-derived 5,5’-
dimethyl-1,3-dioxane 3-20b did not react with cyclopentadiene (vide supra), the reaction 
of acrolein-derived 5,5’-dimethyl-1,3-dioxane 3-20g resulted in the formation of the 
corresponding cycloadduct 3-21g (85% yield, 69:31 e.r., 7:1 d.r.). Finally, the reaction of 
vinyl dioxolane and 2,3-dimethyl-1,3-butadiene resulted in enantioselective formation of 
3-21h (43% yield, 70:30 e.r.) indicating that other dienes could also be employed for this 
reaction.  
3.3 Discussion 
While a conclusive mechanistic and computational investigation delineating the 
nature of the reaction intermediates is yet to be conducted, a tentative mechanism is 
summarized in Scheme 3.2. Thus, initial protonation of an unsaturated acetal with N-
triflylphosphoramide 3-22 results in the reversible formation of the contact ion pair 3-23. 
The subsequent reversible ionization results in the unsaturated oxocarbenium ion 3-24 that 
undergoes a rate-limiting reaction with a diene. The cyclization of the resultant ionic 
cycloadduct 3-25 provides the product and regenerates the catalyst 3-22. At the moment, 
it is not clear whether this reaction proceeds through a clearly defined oxocarbenium ion-
like transition state 3-27 or through the transition state 3-26, in which the breakage of the 
C–O bond is coupled with the cycloaddition event. It is clear that the acidity of the catalyst, 
coordinating ability of the counterion (see Chapter 2), and the reactivity of the dienophile 
play an important role in this reaction. Further mechanistic and computational studies will 
help to shed some light on the nature of the reaction intermediates and the transition states 
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(3-26 versus 3-27) and aid the design of superior catalysts for this and related 
transformations. 
Scheme 3.2 Proposed reaction mechanism  
3.4 Conclusion 
In summary, this chapter describes the first example of an asymmetric chiral N-
triflylphosphoramide-catalyzed ionic DA reaction. This reaction presumably proceeds 
through the intermediacy of a vinyl oxocarbenium/chiral anion pair, and the chiral N-
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triflylphosphoramidate anion controls the stereoselectivity of the cycloaddition step. 
Moderate enantioselectivities (up to 80:20 e.r.) have been obtained when α,β-unsaturated 
dioxolanes were employed as the dienophiles. These reactions demonstrate a strong 
dependence on the counterion coordinating properties and solvent polarity, a behavior 
characteristic of oxocarbenium ions. Demonstrated that chiral Brønsted acid-catalyzed 
activation of acetals could be more generally employed as an alternative to the Lewis or 
Brønsted acid-catalyzed LUMO activation of the α,β-unsaturated carbonyls. Other 
Brønsted acid-catalyzed transformations of α,β-unsaturated acetals as well as design of 
chiral thiophosphoramides as co-catalysts for ionic DA reaction reported herein are the 
subjects of the ongoing studies. 
3.5 Experimental 
Unless otherwise stated, all reagents were purchased from commercial suppliers 
and used without purification. Toluene (PhMe), tetrahydrofuran (THF), dichloromethane 
(CH2Cl2) and diethyl ether (Et2O) were filtered through a column (Innovative Technology 
PS-MD-5) of activated alumina under nitrogen atmosphere. Ethyl isobutyrate (iPrCO2Et) 
was dried with activated 4 Å molecular sieves according to the previously reported 
procedure by Smithers et.al. All reactions were carried out under an atmosphere of nitrogen 
in flame- or oven-dried glassware with magnetic stirring. Reactions were cooled via 
external cooling baths: ice water (0 °C), Neslab Cryotrol CB-80 immersion cooler (0 to -
60 °C) or Neslab Cryocool immersion cooler CC-100 II. Purification of the reactions 
mixtures was performed by flash chromatography using SiliCycleSiliaFlash P60 (230-400 
mesh) silica gel. The enantiomeric ratios (e.r.) were determined on Alliance Waters 
(separations module e2695, detector 2998) using CHIRALCEL OD-H column (4.6 mm x 
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250 mm, 5 μm) by comparing the samples with the appropriate racemic mixtures. 1H NMR 
spectra were recorded on Varian vnmrs 700 (700 MHz), Varian vnmrs 500 (500 MHz), 
Varian MR400 (400 MHz), Varian Inova 500 (500 MHz) spectrometers and chemical shifts 
(δ) are reported in parts per million (ppm) with solvent resonance as the internal standard 
(CDCl3 at δ 7.26). Data are reported as (br = broad, s = singlet, d = doublet, t = triplet, q = 
quartet, qn = quintet, sext = sextet, m = multiplet; coupling constant(s) in Hz; integration). 
Proton-decoupled 13C NMR, as well as 19F and 31P spectra were recorded on Varian vnmrs 
500 (500 MHz) or Varian vnmrs 700 (700 MHz) spectrometers and chemical shifts (δ) are 
reported in ppm with solvent resonance as the internal standard (CDCl3 at δ 77.2). High 
resolution mass spectra (HRMS) were recorded on MicromassAutoSpecUltima or VG 
(Micromass) 70-250-S Magnetic sector mass spectrometers in the University of Michigan 
mass spectrometry laboratory. Infrared (IR) spectra were recorded as thin films on NaCl 
plates on a Perkin Elmer Spectrum BX FT-IR spectrometer. Absorption peaks were 
reported in wavenumbers (cm-1). All previously reported phosphoramides were prepared 
according to published procedures.9 All commercially unavailable acetals and ketals were 
prepared following the procedure reported by Lu and coworkers.10 Racemic Diels-Alder 
reactions were performed according to the Chavan procedure.11 Products were then 
purified by flash chromatography or preparatory HPLC (Waters Delta 600, column Agilent 
Zorbax RX-SIL, 21.2 x 250 mm, 7μm) to ensure high purity standards for developing chiral 
HPLC assays. 
Synthesis of catalysts 3-10 – 3-19.  
Catalysts 3-10,12 3-11,9a 3-13,9b 3-14,9c 3-18,9c 3-18,9d and 3-199e have been synthesized 
according to the previously published procedures. 
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N-((11bS)-2,6-bis(3,5-di-tert-butylphenyl)-4-
oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)-
1,1,1-trifluoromethanesulfonamide (3-12). 
75.2 mg (0.104 mmol) of the corresponding chiral phosphoric acid 
was dissolved in 0.91 mL of dry 1,2 dichloroethane under nitrogen 
atmosphere. Then 1.0 μL (0.0135 mmol) of DMF and 44.5 μL (0.519 mmol) of oxalyl 
chloride were added. The resulting mixture was stirred at reflux for 20 h. After reaction 
completion volatiles were evaporated, the product was dried under high vacuum, and 
subjected to the next step without further purification. This product was isolated as a yellow 
solid, 77.1 mg, quantitative yield; IR (thin film, cm-1) 2962, 2868, 1595, 1477, 1406, 1363, 
1317, 1239, 1086, 922, 751. 1H NMR (400 MHz, CDCl3) δ 8.11 (d, J = 9.4 Hz, 2H), 8.02 
(dd, J = 8.3, 4.8 Hz, 2H), 7.64 (d, J = 1.5 Hz, 2H), 7.58-7.51 (m, 2H), 7.47 (s, 4H), 7.44 
(d, J = 8.6 Hz, 1H), 7.38-7.31 (m, 3H), 1.38 (s, 18H), 1.37 (s, 18H); 13C NMR (175 MHz, 
CDCl3) 151.0, 150.8, 144.52, 144.46, 144.4, 135.7, 135.5, 134.9, 132.1, 132.0, 131.7, 
128.8, 128.7, 127.4, 127.3, 126.94, 126.89, 126.64, 126.62, 124.7, 123.0, 122.7, 121.9, 
35.3, 35.2, 31.7; 31P NMR (202 MHz, CDCl3) δ 8.4 (s); HRMS (ESI+) (m/z): [M+Na] calcd 
for C48H52ClO3PNa 765.3235; found 765.3216. 
A solution of 16.3 mg (0.110 mmol) of trifluoromethanesulfonylamide in 0.5 mL 
of dry THF was treated with freshly prepared solution of LDA (made from 30.7 μL (0.219 
mmol) diisopropylamine, 0.14 mL 1.6 M (0.219 mmol) n-butyllithium and dry THF (0.5 
mL) at -78 oC. The resulting solution was cannulated over a solution of phosphoryl chloride 
prepared above in dry THF (0.9 mL) again at -78 oC. The resulting reaction mixture was 
refluxed for 16 h. After that the reaction mixture was brought to room temperature and 
quenched with water. Organic products were extracted with DCM. Extract was then 
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washed with 4N HCl and dried over anhydrous magnesium sulfate. The desired product 
was purified via preparatory TLC (10:1 DCM/Et2O) and washed again with 4N HCl to 
provide a white solid, 42.2 mg, 49% yield; IR (thin film, cm-1) 2961, 2922, 2869, 1595, 
1432, 1364, 1203, 1151, 910, 733. 1H NMR (700 MHz, CDCl3) δ 8.15 (s, 1H), 8.06 (s, 
1H), 8.02 (d, J = 8.3 Hz, 1H), 7.99 (d, J = 8.3 Hz, 1H), 7.58-7.51 (m, 5H), 7.51-7.42 (m, 
4H), 7.38-7.30 (m, 3H), 1.37 (s, 18H), 1.34 (s, 18H); 13C NMR (175 MHz, CDCl3) 151.5, 
150.9, 144.0, 143.5, 135.7, 135.2, 134.9, 134.3, 132.3, 132.03, 131.99, 131.96, 128.8, 
128.6, 127.4, 127.3, 127.0, 126.6, 124.6, 124.4, 122.9, 122.8, 122.5, 122.2, 35.21, 35.18, 
31.6; 31P NMR (283 MHz, CDCl3) δ -11.0 (s); 19F NMR (376 MHz, CDCl3) δ -77.4; HRMS 
(ESI-) (m/z): [M-H] calcd for C49H52F3NO5PS 854.3259; found 854.3259. 
N-((2s,11bS)-4-oxido-2,6-bis(2,4,6-triisopropyl-
phenyl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosph-
epin-4-yl)methanesulfonamide (3-16).  
Following the procedure described by Yamamoto and 
Nakashima,9a the preparation of 3-16 was conducted on 0.28 mmol scale from the 
corresponding BINOL derivative and sulfonamide.  The resultant product, was isolated as 
a white solid, 60 mg, 26% yield; IR (thin film, cm-1) 2961, 2870, 1381, 1315, 1171, 912. 
1H NMR (700 MHz, CDCl3) δ 8.00-7.94 (m, 4H), 7.58-7.53 (m, 2H), 7.39-7.33 (m, 3H), 
7.29-7.26 (m, 1H), 7.15 (dd, J = 3.1, 1.9 Hz, 2H), 7.13 (d, J = 1.7 Hz, 1H), 7.02 (d, J = 1.7 
Hz, 1H), 2.98-2.95 (m, 3H), 2.73-2.68 (m, 1H), 2.60-2.52 (m, 2H), 2.42 (s, 3H), 1.43 (s, 
1H), 1.30 (d, J = 7.2 Hz, 6H), 1.26 (d, J = 6.9 Hz, 9H), 1.24 (dd, J = 10.0, 6.9 Hz, 6H), 
1.21 (dd, J = 6.9, 1.9 Hz, 6H), 1.09 (d, J = 6.9 Hz, 3H), 1.00 (d, J = 6.9 Hz, 3H), 0.96 (d, J 
= 6.9 Hz, 3H); 13C NMR (175 MHz, CDCl3) δ 149.9, 149.2, 148.7, 148.3, 147.2, 146.2, 
146.0, 144.6, 133.0, 132.9, 132.6, 132.4, 132.3, 131.8, 131.3, 130.9, 130.7, 130.2, 128.6, 
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128.5, 127.5, 126.9, 126.5, 126.4, 122.1, 121.7, 121.6, 121.3, 120.3, 42.1, 34.6, 31.6, 31.4, 
31.2, 30.8, 30.5, 29.9, 27.1, 27.0, 25.6, 25.2, 24.4, 24.2, 23.3, 23.2, 23.1; 31P NMR (202 
MHz, CDCl3) δ -4.5 (s); HRMS (ESI+) (m/z): [M-H] calcd for C51H59NO5PS 828.3857; 
found 828.3854. 
2,3,4,5,6-pentafluoro-N-(4-oxido-2,6-bis(2,4,6-tri-
isopropylphenyl)di-naphtho[2,1-d:1',2'-f][1,3,2]-
dioxaphosphepin-4-yl)benzenesulfonamide (3-17).  
Following the procedure described by Yamamoto and 
Nakshima,19a the preparation of 3-17 was conducted on 
0.117 mmol scale from the corresponding BINOL derivative and sulfonamide.  The 
resultant product, 11.6 mg was isolated as a white solid in 10% yield; IR (thin film, cm-1) 
2961, 2928, 2870, 1520, 1504, 1409, 1316, 1302, 1182, 1103, 996, 903, 733. 1H NMR (700 
MHz, CDCl3) δ 8.02-7.91 (m, 4H), 7.60-7.51 (m, 2H), 7.42-7.29 (m, 4H), 7.22 (d, J = 8.9 
Hz, 2H), 7.12 (d, J = 1.4 Hz, 1H), 7.06 (d, J = 1.4 Hz), 3.05-2.92 (m, 2H), 2.82-2.73 (m, 
1H), 2.68-2.50 (m, 3H), 1.32 (d, J = 6.8 Hz, 12H), 1.26 (d, J = 6.8 Hz, 6H), 1.23-1.15 (m, 
9H), 1.04 (d, J = 6.8 Hz, 3H), 0.98 (d, J = 6.8 Hz, 3H), 0.94 (d, J = 6.8 Hz); 13C NMR (175 
MHz, CDCl3) δ 150.4, 148.9, 148.5, 147.7, 146.9, 146.3, 133.6, 133.2, 132.9, 132.4, 132.2, 
131.8, 131.3, 130.3, 130.1, 129.8, 128.6, 127.7, 127.6, 126.9, 126.6, 126.5, 122.1, 122.0, 
121.5, 121.4, 120.6, 34.6, 34.4, 31.8, 31.3, 31.2, 30.5, 29.9, 27.5, 26.9, 25.6, 25.4, 24.1, 
24.0, 23.2, 23.1, 23.0, 22.7; 31P NMR (202 MHz, CDCl3) δ -6.0 (s); 19F NMR (376 MHz, 
CDCl3) δ -135.3 (d, J = 21.9 Hz, 2F), -144.9-(-145.2) (m, 1F), -159.6 (t, J = 19.1 Hz, 2F);  
HRMS (ESI-) (m/z): [M-H] calcd for C56H56F5NO5PS 980.3542; found 980.3541.
 
Preparation of acetals 3-20 in Table 3.4. The unsaturated acetals 3-6,10 3-20a,13 3-20b,13 
3-20c,14 3-20d,13c and 3-20g,13f have been synthesized according to previously published 
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procedures. Acetal 3-20e was synthesized from the corresponding aldehyde following the 
protocol provided below. Acetal 3-20f was purchased from Sigma-Aldrich and used as 
received. 
(E)-2-(2-cyclohexylvinyl)-1,3-dioxolane (3-20e).  
(E)-3-Cyclohexylacrylaldehyde (768.0 mg, 5.56 mmol) was dissolved in 
6.8 mL of dry toluene, followed by addition of L-tartaric acid (10.2 mg, .0680 mmol) and 
anhydrous magnesium sulfate (869.4 mg, 7.22 mmol). The setup was flushed with nitrogen 
and then ethylene glycol was added (0.81 mL, 14.5 mmol). The reaction mixtrure was 
refluxed with a Dean-Stark column overnight. The reaction was quenched with 0.1 mL of 
triethylamine and then solids were quickly filtered off. The filtrate was then concentrated 
in vacuo and the desired product was purified by column chromatography. Light yellow 
oil, 60% yield; IR (thin film, cm-1) 2924, 2852, 1674, 1449, 1400, 1139, 1064, 963. 1H 
NMR (700 MHz, CDCl3) δ 5.89 (dd, J = 15.7, 6.5 Hz, 1H), 5.42 (ddd, J = 15.7, 6.7, 1.5 
Hz, 1H), 5.17 (d, J = 6.7 Hz, 1H), 4.03-3.97 (m, 2H), 3.92-3.86 (m ,2H), 2.04-1.97 (m, 
1H), 1.78-1.68 (m, 4H), 1.67-1.61 (m, 1H), 1.30-1.22 (m ,2H), 1.15 (tt, J = 12.7, 3.4 Hz, 
1H), 1.12-1.05 (m, 2H); 13C NMR (175 MHz, CDCl3) δ 143.8, 123.8, 104.8, 65.1, 40.2, 
32.4, 26.3, 26.1; HRMS (EI) (m/z): [M-H] calcd for C11H17O2 181.1229; found 181.1224.  
General procedure A for enantioselective Diels-Alder reactions. 
An oven-dried 4-mL scintillation vial was charged with 1 eq of a dienophile and 5 mol% 
of a catalyst, capped with septum and flushed with nitrogen. Ethyl isobutyrate was then 
added to ensure 0.3 M concentration of dienophile. Cyclopentadiene (2 eq) was then added 
via micro syringe. The resulting reaction mixtrure was stirred at room temperature for 16 
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hours and then the reaction was quenched with about 2 eq of triethyl amine. Then triphenyl 
methane was added and volatiles were evaporated from the reaction vial. The crude mixture 
was analyzed by quantitative 1H NMR and HPLC.  
General procedure B for enantioselective Diels-Alder reactions.  
An oven-dried 4-mL scintillation vial was charged with 5 mol% of a catalyst, capped with 
septum and flushed with nitrogen. Ethyl isobutyrate was then added to ensure 0.3 M 
concentration of dienophile. After that 1 eq of a dienophile and 2 eq of diene were added 
via micro syringe. The resulting reaction mixtrure was stirred at room temperature for 16-
24 hours and then the reaction was quenched with about 2 eq of triethyl amine. Then, 
triphenyl methane was added and the crude mixture was analyzed by quantitative 1H NMR 
and HPLC.  
Characterization data for the cycloadducts 3-21 in Table 3.4.  
The cycloadducts 3-7,11 3-21c,15 3-21g,11 and 3-21h,16 have been previously characterized. 
The characterization data for compounds 3-21a, and 3-21e is provided below. The crude 
product 3-21d was hydrolyzed to the corresponding ketone that has been synthesized and 
characterized before.17 The hydrolysis procedure is provided below. 
Hydrolysis of cycloadduct 3-21d.  
The crude reaction mixture was obtained following the General Procedure A described 
above. The reaction was quenched with ~10 mol% of triethylamine. Volatiles were 
evaporated from the reaction mixture, and then the resultant mixture was dissolved in 
dioxane (1.0 mL).  To this, 4N HCl (0.5 mL) was added, the resultant mixture was stirred 
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at 40 ºC for 2 h, then organics were extracted with diethyl ether. Organic layer was dried 
with MgSO4 and filtered. The solvent was removed in vacuo and triphenylmethane was 
added. The resultant crude mixture was analyzed by 1H NMR to establish the yield and 
d.r.17 
2-(3-phenylbicyclo[2.2.1]hept-5-en-2-yl)-1,3-dioxane (3-21a). 
Colorless oil, 32% yield (about 60% conversion) 12:1 endo/exo; IR (thin 
film, cm-1) 3057, 2964, 2847, 1498, 1377, 1240, 1144, 1110, 1011, 720, 700. Endo product: 
1H NMR (400 MHz, CDCl3) δ 7.39 (d, J = 7.6 Hz, 2H), 7.28 (t, J = 7.6 Hz, 2H), 7.16 (t, J 
= 7.3 Hz, 1H), 6.34 (dd, J = 5.6, 3.1 Hz, 1H), 6.15 (dd, J = 5.6, 2.8 Hz), 4.15-4.03 (m, 2H), 
4.05 (d, J = 8.3 Hz, 1H), 3.75-3.62 (m, 2H), 3.02 (s, 1H), 2.93 (s, 1H), 2.49-2.45 (m, 1H), 
2.45-2.39 (m, 1H), 2.13-1.99 (m, 1H), 1.66 (d, J = 8.6 Hz, 1H), 1.46 (dq, 8.6, 1.7 Hz, 1H), 
1.32-1.26 (m, 1H). Distinct peaks for exo product: 1H NMR (400 MHz, CDCl3) δ 6.29 (dd, 
J = 5.5, 3.1 Hz, 1H), 5.92 (dd, J = 5.5, 2.9 Hz, 1H), 5.71-5.60 (m, 1H), 4.55 (d, J = 6.4 Hz, 
1H), 3.21 (dd, J = 5.0, 3.5 Hz, 1H), 3.08 (br s, 1H), 2.98 (br s, 1H), 1.94-1.89 (m, 1H), 1.75 
(d, J = 8.6 Hz, 1H), 1.34 (br s, 1H); Endo only: 13C NMR (175 MHz, CDCl3) δ 145.3, 
138.1, 135.4, 128.4, 128.1, 125.8, 106.8, 67.1, 51.5, 49.4, 47.0, 46.7, 44.3, 26.0; HRMS 
(ESI+) (m/z): [M+NH4] calcd for C17H24NO2 274.1802; found 274.1800. 
2-(3-cyclohexylbicyclo[2.2.1]hept-5-en-2-yl)-1,3-dioxolane (3-21e).  
Light yellow oil, 60% yield, 3:1 endo/exo; IR (thin film, cm-1) 2980, 2922, 
2851, 1448, 1334, 1098, 1056, 990, 719. Endo product: 1H NMR (400 MHz, CDCl3) δ 
6.18-6.13 (m, 1H, endo/exo), 6.09-6.04 (m, 1H, endo/exo), 4.26 (d, J = 7.6 Hz, 1H, endo), 
4.03-3.88 (m, 2H, endo/exo), 3.88-3.73 (m, 2H, endo/exo), 2.88 (br s, 1H, endo/exo), 2.75 
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(br s, 1H, endo), 1.94-1.85 (2H, endo/exo), 1.80-1.70 (m, 2H, endo/exo), 1.68-1.53 (m, 2H, 
endo/exo), 1.41 (d, J = 8.5 Hz, 1H, endo), 1.31 (dd, J = 8.5, 1.4 Hz, 1H, endo/exo), 1.29-
1.08 (m, 4 H, endo/exo), 1.06-0.86 (m, 3H, endo/exo) Selected 1H NMR peaks for exo 
product: 1H NMR (400 MHz, CDCl3) δ 4.83 (d, J = 5.0 Hz, 1H), 2.80 (br s, 1H); Endo 
only: 13C NMR (175 MHz, CDCl3) δ 138.1, 134.6, 108.9, 65.0, 64.7, 48.2, 47.6, 46.7, 44.6 
(2H), 42.3, 32.9, 32.3, 27.1, 26.9 (2H); MS (EI) (m/z): [M] calcd for C16H24O2 248.2; found 
248.2. 
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Chapter 4 
Stereo- and Regioselective Synthesis of Aminoglycosides 
4.1 Introduction to aminoglycosides 
Since the glucose structure elucidation by E. Fisher in 18911, the carbohydrate 
chemistry became a fascinating field for the organic synthesis community. Many methods 
were developed for the synthesis of complex carbohydrates. Carbohydrates are abundant 
as they are found in a plethora of natural products, and they have endless number of 
functions within the human body as well as all other organisms. Cellular and protein 
recognition is one of the major functions in biological processes that includes 
carbohydrates. For example, glycoproteins and glycolipids are overexpressed or modified 
on the cancer cell membranes.2,3 
As a part of carbohydrate family, aminoglycosides represent an important subclass 
of carbohydrate chemistry. Aminoglycosides are broad-spectrum antibiotics typically used 
for treatment of serious bacterial infections. These antibiotics target the prokaryotic 
ribosome by binding to the decoding A-site of the 16S rRNA fragment while interfering 
protein translation.4 Aminoglycoside antibiotics typically display bactericidal activity 
against Gram-negative aerobic bacteria and some anaerobic bacilli, and generally not 
against Gram-positive or anaerobic Gram-negative bacteria. The first isolation of a known 
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naturally available aminoglycoside streptomycin from Streptomyces griseus by Schatz and 
Waksman in 19445, multiple naturally available aminoglycoside antibiotic agents were 
discovered (Figure 4.1). Aminoglycosides are composed of several aminocarbohydrate 
units that are glycosidically bound to an aminocylitol ring (either streptamine or 2-
deoxystreptamine).6  
The substitution pattern on aminocylitol rings vary substantially depending on the 
aminoglycoside. Thus, 2-deoxystreptamine, the central core in most popular 
aminoglycosides can be substituted at positions 4 and 5 (neomycin, paroromycin, and 
ribostamycin), or at positions 4 and 6 (amikacin, kanamycin A and B, tobramycin, 
gentamycin etc.), while streptidine core is found in streptomycin (Figure 4.1).  
Naturally occurring aminoglycosides are produced by Streptomyces and 
Micromonospora soil bacteria, which proactively methylate their ribosomes to survive the 
bactericidal action of their secondary metabolites.7 There are three major pathways that 
lead to bacterial resistance to aminoglycosides: enzymatic modification by 
aminoglycoside-modifying enzymes, reduction of the drug-target activity by modification 
of 30S fragment of the A-site of rRNA, or active removal of aminoglycoside from the 
bacterial cell through efflux pumps. Along with some developed resistance, 
aminoglycosides also sometimes cause nephro- and oto-toxic, as well as neuromuscular 
side effects. Molecular mechanisms that lead to the side effects are not yet completely 
understood and are the subject of several medicinal studies.6 Overall, aminoglycosides 
show a strong synergistic effect when coadministered with penicillin, a particularly useful 
combination for treatment of infections of unknown origin.8 Some semisynthetic 
derivatives such as amikacin, netilimicin, arbekacin etc. are also on the market due to 
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particular activity against bacteria that developed resistance against early 
aminoglycosides.9 However, in recent years it became obvious that the battle against 
bacterial resistance is not over. On the contrary, resistance of bacterial strains is reported 
with increasing frequency, with the associated severe consequences such as untreatable 
patients or temporary closure of hospital intensive cares.8  
Aside from antibiotic activity, aminoglycosides are gaining popularity in the field 
of potentially broader application, that is, regulation of protein production at RNA level. 
Since aminoglycosides are rather unselective ligands for all sorts of RNA, often in low 
micromolar concentration, their characteristics have been extensively studied in the field 
of “RNA as a drug target”: the understanding that RNA plays a central role in protein 
production from DNA provides wide opportunities for pharmaceutical development.  
Drug resistance, high levels of toxicity, and the variety of biological activities of 
aminoglycosides and their synthetic analogs have encouraged chemists to develop 
chemical strategies and methodologies for the design and preparation of novel 
aminoglycosides. It was our objective to develop a regio- and stereoselective method for 
synthesis of aminoglycoside derivatives using chiral Brønsted acids as catalysts. 
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Figure 4.1 Structural diversity of natural aminoglycoside antibiotics 
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4.2 Strategy for regio- and stereoselective glycosylations of 2-
deoxystreptamine 
As seen from Figure 4.1, members of aminoglycoside family are predominantly 
built up by a variety of aminosugars. These aminosugars, often 6-amino or 2,6-diamino 
type can be additionally decorated or functionalized. Some additional rings or rare 
carbohydrates can be present in some aminoglycosides, however of higher significance is 
the aminocyclitol that is present in each of the structures. 2-deoxystreptamine is a central 
core in most aminoglycosides. Due to the presence of many amino functionalities, 
aminoglycosides are heavily protonated under physiological conditions, thus providing a 
rationale for the strong affinity for nucleotides in RNA.10  
The omnipresence and central location of 2-deoxystreptamine (or in some cases 
other aminocyclitols) suggests a crucial role for biological activity. X-Ray structures of 
several aminoglycosides complexed to the 30S ribosomal particle11,12,13 or to an A-site 
oligonucleotide sequence14,15,16 without exception show a similar binding pattern to 2-
deoxystreptamine regardless its 4,5- or 4,6-substitution. Additional evidence of the crucial 
role of 2-deoxystreptamine in biological activity of aminoglycosides comes from the 
observation that the presence of bivalent structure of 2-deoxystreptamine alone, without 
aminosugar substitution, already shows low micromolar binding to RNA hairpin loops.17 
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Figure 4.2 2-Deoxystreptamine and its synthons 
High activity of 2-deoxystreptamine and diversity of carbohydrate residues that 2-
deoxystreptamine is bound with suggests that glycodiversification of 2-deoxystreptamine 
4-1 could potentially be a valid strategy for design and synthesis of novel aminoglycosides. 
2-Deoxystreptamine is an all-trans substituted meso molecule that has two amino and three 
hydroxyl groups (Figure 4.2A). Numerous synthetic strategies have been developed in 
order to access 2-deoxystreptamine, many of which begin with chiral starting materials 
(Figure 4.2B). Considering the fact that 2-deoxystreptamine is a symmetric molecule, the 
choice of an enantiomerically pure starting material might seem awkward at first, however 
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that provides access to useful enantiomerically pure intermediates that can be applied for 
the synthesis of novel aminoglycosides.  
Our approach, however, implies the use of meso starting material that will be 
desymmetrized using chiral Brønsted acids. Such desymmetrization would proceed 
through either stereoselective protection of alcohol groups or their direct glycosylation 
when catalyzed by chiral phosphoric acids or their derivatives (Scheme 4.1). 
Scheme 4.1 Proposed desymmetrization of 2-deoxystreptamine derivative 
The enantioselective desymmetrization of meso-diols is one of the most popular 
methods to access the corresponding monoprotected derivatives in their enantiopure form. 
The nonenzymatic desymmetrization of meso-diols has been achieved through asymmetric 
monoacylation,18silylation,19 hydrolysis of acetals,20 hydrolysis of meso-diesters, oxidation 
of diols, etc.21 While those approaches commonly include use of chiral amines or chiral 
Lewis acids as catalysts, up until 2015 no methods for desymmetrization of meso-diols 
catalyzed by chiral Brønsted acids were available.19d 
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Scheme 4.2 CPA-controlled regioselective acetalization of chiral diols and 
enantioselective desymmetrization of meso-diols 
In 2013 our group published a method for chiral phosphoric acid-directed 
regioselective acetalization of carbohydrate-derived 1,2-diols (Scheme 4.2).22 This method 
combines the approach of CPA-catalyzed nucleophilic addition to oxocarbenium ions as 
well as differentiation of two alcohol groups that are present in the same molecule. This 
was the first study that presented catalyst-controlled (rather than substrate- or reagent-
controlled) regioselective acetalization reaction. In addition to that, preliminary studies in 
desymmetrization of meso-diols via acetalization using chiral phosphoric acids was 
reported as well. This approach was later used in attempt to desymmetrize 2-
deoxystreptamne derivatives (vide infra). 
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Scheme 4.3 CPA mediated glycosylation with recognition of alcohol chirality 
Another way to desymmetrize 2-deoxystreptamine is to do a glycosylation reaction 
without prior enantioselective protection of meso-2-deoxystreptamine. Chiral phosphoric 
acids have shown that they can promote glycosylation reaction between 
trichloroacetimidate glycosyl donors and acceptors, often enhancing the α/β 
selectivities.23,24,25 In addition to α/β selectivity, chiral phosphoric acids proved to perform 
chiral recognition of racemic alcohols during the glycosylation reaction with sufficiently 
high selectivity (Scheme 4.3).24 The aforementioned reports by our group22 and Toshima 
suggest that chiral phosphoric acids can potentially be used as catalysts for regio- and 
stereoselective glycosylation of 2-deoxystreptamine derivative. 
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4.3 Design of 2-deoxystreptamine derivatives for its desymmetrization 
While many synthetic pathways exist that allow to access enantiomerically pure 
chiral 2-deoxystreptamine derivatives, the most practical way to obtain 2-
deoxystreptamine is by straightforward acidic degradation of neomycin B (Scheme 4.4). 
This is the approach we are also using to access 2-deoxystreptamine. 
Scheme 4.4 Acidic degradation of neomycin 
As it was mentioned before, 2-deoxystreptamine is a polar molecule that has two 
amino and three hydroxyl groups. These five polar functionalities make 2-
deoxystreptamine extremely hydrophilic making it soluble only in water. Presence of water 
in the reaction catalyzed with a chiral Brønsted acid will lead to specific acid catalysis 
which will result in low stereoselectivities due to solvent association of the chiral acid 
anion. Hence, in order to perform enantio- or diastereoselective reactions using chiral 
Brønsted acids as catalysts, it is extremely important to eliminate all the water from the 
reaction mixture. In addition to that, it is also necessary to protect basic nitrogens since 
amines react with Brønsted acids. Thus, a variety of nitrogen (and oxygen) protecting 
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groups had to be considered in order to make the meso-triol more lipophilic and less basic 
(Figure 4.3).  
Figure 4.3 Nitrogen protecting groups for 2-deoxystreptamine 
First carbamate-based protective groups were selected in order to test their effects 
on the solubility of 2-deoxystreptamine. Thus, Boc and Alloc groups were installed. The 
lipophilic character of those groups suggested that the product could potentially be far more 
soluble in non-polar organic solvents than the unprotected diamine. While both Boc and 
Alloc groups made the substrate more soluble in methanol, 4-3 and 4-4 were still rather 
poorly soluble in other organic solvents such as chloroform or benzene (Scheme 4.5 A). 
Hence, to increase the solubility even more, a benzyl protecting group was introduced as 
well. While benzyl protecting group in combination with Alloc or Boc protection gave 
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greater increase in solubility; however, complicated the detection and analysis of 4-5 and 
4-6 by NMR spectroscopy due to the formation of the C-N bond rotamers (Scheme 4.5 B). 
Since we anticipated that the NMR techniques would be key in analyzing and interpreting 
the acetalization or glycosylation of 2-deoxystreptamine results, compounds 4 and 5 were 
abandoned as potential substrates for the study. 
Scheme 4.5 Synthesis of 4-3 – 4-6 
Phtalimide is another common protective group for nitrogen. The substitution of 
primary amine with a phtalimide protective group allows to block both hydrogens on 
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nitrogen to avoid secondary hydrogen bond interaction with the chiral catalyst or the 
glycosyl donor. The synthesis of phtalimides proceeds through dehydrative condensation 
of phtalic anhydride at high temperatures with primary amines. Thus, two phtalimide 
groups were introduced to 2-deoxystreptamine that resulted in formation of methanol 
soluble 4-8. While 4-8 was proved to be insoluble in nonpolar solvents, tert-
butylphtalimide-derived 2-deoxystreptamine 4-9 was rather soluble in dichloromethane 
and ethyl acetate (Scheme 4.6).  
Scheme 4.6 Synthesis of 4-8 – 4-9 
Finally, azides were also explored as a protecting group of nitrogen. Small steric 
size of azides would be beneficial for reasonably bulky chiral phosphoric acids. Thus, 
diazotransfer reaction was performed with trifluoromethasulfonic anhydride and sodium 
azide (Scheme 4.7). While original procedure26 reported 69% yield for the double diazo 
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transfer on 2-deoxystreptamine, the observed yield in our case was nearly quantitative. This 
alarming observation was carefully studied. Although 1H NMR showed no impurities 
present in the crystalline product, 19F NMR suggested strong presence of some fluorine 
containing impurity, probably trifluoromethasulfonylamide (TfNH2), a byproduct in 
diazotransfer reactions where both sodium azide and Tf2O are used. The evaluation of the 
product mixture revealed that most of the material consisted of TfNH2 with only minor 
amounts of the desired diazide 4-7. Unfortunately, the properties of both the diazide and 
TfNH2 made the separation of two impossible by column chromatography. Hence, another 
diazotransfer reaction strategy had to be employed.  
Scheme 4.7 Diazotransfer with trifluoromethanesulfonic anhydride 
In 2007 Goddard-Borger reported preparation and application of a novel imidazole-
1-sulfonyl azide hydrochloride (Scheme 4.8). This diazotransfer reagent allows to 
circumvent formation of TfNH2.
27 However, shock sensitivity and heat stability of low-
molecular weight azides has always been a cause for concern. While the original paper 
reported that 4-12·HCl is neither shock nor heat sensitive, there was an actual explosion 
during the synthesis of 4-12·HCl. Thus, Goddard-Borger in collaboration with Klapotke 
studied the sensitivities of imidazole-1-sulfonyl azide salts.28 All salts investigated proved 
to be equally good diazo donors, however their safety profile varied substantially. All 
things considered, 4-12·HBF4 and 4-12·H2SO4 are the safest-to-handle materials. Since 
hydrogen sulfate is easier and less expensive to prepare, it became the diazotransfer reagent 
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of our choice. It is important to note that imidazole-1-sulfonyl azide and its salts are 
energetic materials and should be handled with caution. Plastic filters and suction funnels 
should be used for the isolation of crystalline materials. Mother liquors and any other waste 
should be treated with excess sodium nitrite and acidified to neutralize any azide-
containing species.  
2-Deoxystreptamine diazide 4-7 was synthesized using Goddard-Borger method 
(Scheme 4.8), and was sufficiently soluble in solvents such as dichloromethane and 
chloroform. Due to its rather sterically unencumbered structure, as well as simplicity of its 
synthesis (1 step, 51% yield vs 3 steps, 20% yield for 4-9), azide was selected as protecting 
group of choice. In general, the introduction of an azido group into a molecule typically 
increases its energy content by 69–85 cal/mol. Organic azides are considered as explosives 
whenever the nitrogen content in the molecule is abnormally high. As a rule of thumb, 
violent decomposition reactions can be expected for azido compounds having (C + O)/N 
ratio of < 3.29 Thus, 4-7 having two azido groups brings this ratio to 1.5. Since 4-7 might 
be potentially explosive, it was important to study its stability. 
Scheme 4.8 Diazotransfer with imidazole-1-sulfonyl azide 
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There are several tests available to evaluate the stability of organic azides. The 
impact sensitivity of energetic compounds is tested with a so-called fall hammer 
equipment. Samples are exposed to the impact of a falling weight from variable heights 
and the measured sensitivity parameter is the height at which the samples explode or 
decompose. The drop test was performed on diazo-2-deoxystreptamine 4-7 and it showed 
some mild shock sensitivity. Thus, 10 mg of the sample went off when 1 lbs weight was 
dropped from 145 cm height; however, it did not explode or decompose when the same 
weight was dropped from 125 cm height. While this test gave us only preliminary data, it 
became clear that 4-7 has to be treated with caution. Hence, the azide 4-7 has always been 
stored in desiccated area, in small, up to 200 mg quantities. Differential Scanning 
Calorimetry (DSC) was also performed. It showed that 6 was not thermally sensitive and 
had a melting point of 136 °C.  
As it was mentioned before, chiral phosphoric acids are able to control 
regioselective acetalization of chiral diols and enantioselective desymmetrization of meso-
diols by forming mixed acetals. We decided that chiral phosphoric acids could potentially 
catalyze formation of mixed acetals (Scheme 4.9 A). 
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Scheme 4.9 Desymmetrization of 4-7 via acetal formation 
Thus, the studies commenced with evaluation of phosphoric acids in the presence 
of diazide-2-deoxystreptamine 4-7 and 2-methoxypropene. First, achiral 
diphenylphosphate was used in order to prepare a racemic standard for the chiral HPLC 
assay (Scheme 4.9 B). To our surprise, instead of forming a mixed acetal 4-13, an acetonide 
4-14 was formed instead with no traces of acetal 4-13 present in the mixture. Since the 
reaction produced asymmetric product, we proceeded with evaluation of chiral phosphoric 
acids under the same reaction conditions. The most common chiral phosphoric acids 4-15 
and 4-16 were evaluated. These preliminary results showed that under these conditions 
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asymmetric acetal 4-13 was still not observed, even at very low conversions. Reactions at 
room temperature led to formation of racemic acetonide 4-14 at reasonably low 
conversions after stirring the reaction mixture overnight. When the reaction was performed 
at -30 °C in the presence of 10 mol% of 4-15, the yield dropped substantially, while 
enantioselectivity increased only to 25% ee (Scheme 4.9 C). Slow reaction rates were 
attributed to poor solubility of 4-7, especially at lower temperatures. Thus, poor conversion 
and low enantioselectivities suggested that a protecting group on O-4 could potentially 
improve the enantioselectivity of asymmetric acetalization. In addition to that, direct 
glycosylation reaction studies would benefit from having protection at this position because 
it would lead to formation of fewer regioisomeric glycosides which would simplify the 
reaction analysis substantially. Finally, the protection would increase the molecular weight 
of the bis-azide and thus decrease its shock sensitivity. 
Several oxygen protecting groups were considered. The protecting group had to be 
reasonably non-labile under acidic conditions, as well as it should be possible to put just 
one protecting group on the middle oxygen, avoiding having a statistical mixture of mono- 
and bis-protected 2-deoxystreptamine derivatives. Therefore, several silyl protecting 
groups were evaluated such as TMS, TES and TBS (Scheme 4.10). TMS and TES 
protection resulted in statistical mixture of O-4 and O-3 protected positions, as well as 
some amount of double-protected products. Attempt to isolate either one of those products 
via column chromatography failed due to decomposition and/or rearrangement of the 
products. This suggested sufficient acidic instability and both TMS and TES groups were 
abandoned. On the other hand, TBS protection was rather successful providing O-4 
protection with 45% yield (unoptimized). Since this diol still had reasonably low carbon 
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and oxygen to azide ratio, shock and heat sensitivity tests were also performed on it. As 
before, 4-17 was not heat sensitive based on DSC analysis (m.p. = 110.6 °C). As expected, 
the TBS protection contributed to increased stability of the compound. The drop test 
showed that the sample went off only in 30% of the cases when 1 lbs weight was dropped 
off 145 cm height. Thus, while TBS-protected 2-deoxystreptamine 4-17 is more stable than 
4-7, it still should be handled with great care. 
Scheme 4.10 Hydroxyl protection of 4-7 
Finally, the acetylation reaction provided full statistical mixture of mono-, bis- and 
trisprotected 2-deoxystreptamine derivatives that was too complicated to analyze and 
purify. Attempts to improve the yield for O-4 acetylated product were also unsuccessful. 
With the TBS-protected diol 4-17 in hand, we resumed our acetalization studies 
with a hope to develop a faster desymmetrization of a meso-2-deoxystreptamine derivative. 
Since O-4 was already protected, we assumed that formation of a mixed acetal 4-20 will 
97 
 
take place in presence of 2-methoxypropene and diphenylphosphate (Scheme 4.11). To our 
surprise, however, we observed formation of acetonide 4-19 (~10% conversion) resulting 
from condensation of two diol molecules with one 2-methoxypropene. No formation of 
mixed acetal 4-20 was observed even at lower concentration or with excess of 2-
methoxypropene. An attempt to perform acetalization reaction with 2-
methoxycyclohexene was not successful – only starting material was recovered. Since 
enantioselective desymmetrization of 2-deoxystreptamine did not provide positive 
preliminary studies, it was decided to attempt desymmetrization via glycosylation of meso-
2-deoxystreptamine derivatives. 
Scheme 4.11 Acetalization of 4-17 
To increase the chances of successful glycosylation studies, we synthesized two 
additional glycosyl acceptors 4-24 and 4-25 with allyl and benzyl protection at O-5 
position. To perform regioselective allylation or benzylation of diazido-2-
deoxystreptamine, kanamacyn A was subjected to diazotransfer, followed by treatment 
with allyl- or benzylbromide (Scheme 4.12). The resulted modified 4-22 and 4-23 was then 
hydrolyzed under acidic conditions to produce glycosyl acceptors 4-24 and 4-25.30 Since 
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this synthetic pathway proceeds through formation of intermediates and products rich in 
azide groups, stability tests were also performed. Thus, azidated kanamycin A 4-21, as well 
as both allyl and benzyl protected 2-deoxystreptamine 4-24 and 4-25 proved to be both 
shock and heat insensitive. 
Scheme 4.12 Synthesis of allyl and benzyl protected 2-deoxystreptamines 
4.4 Design of glycosyl donor for glycosylation studies 
Analysis of glycosylation reactions can be rather difficult at times, especially if a 
glycosyl acceptor molecule contains several free hydroxyl groups. Thus, if a glycosyl 
acceptor contains three hydroxyl groups, one can expect to produce at least six isomeric 
disaccharides: three α and three β products plus possibly some amount of trisaccharides 
resulting from double glycosylation of glycosyl acceptor. If, however, a glycosyl acceptor 
contains only two hydroxyl groups, the number of possible outcomes reduces down to four 
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disaccharides with possible addition of trisaccharides. Consequently, it was decided to use 
meso-2-deoxystreptamine-based acceptors with protection at O-5 position.  
The desymmetrizing glycosylation of meso-diols will produce an additional 
anomeric stereocenter and result in desymmetrization of deoxystreptamine subunit (for 
clarity we will refer to the latter as “regioselection” in the following discussions). As the 
determination of the site of glycosylation (i.e. “regioselectivity”) can potentially be 
challenging, it was decided to first design a glycosyl donor, that upon coupling with 2-
deoxystreptamine, would produce a disaccharide that after some protecting group 
manipulations would produce a natural aminoglycoside or its known derivative. This 
would allow us to compare the spectroscopic data and unambiguously assign the 
stereocenters of the glycosylation products. One of the most common glycosyl residues 
that 2-deoxystreptamine bound to is 2,6-diamino-2,6-dideoxyglucose (Figure 4.1, NEA, 
Scheme 4.13) with neamine being the simplest aminoglycoside available. 
Scheme 4.13 Synthesis of neamine by stereodifferentiation of 2-deoxystreptamine 
Hence, by looking at the structure of neamine, one can notice several prerequisites 
for the glycosyl donor. The carbohydrate residue of neamine has amino groups at positions 
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C-2 and C-6 that should be protected if chiral phosphoric acids will be used as catalysts for 
glycosylation reaction. In addition, in this case as well as in case of most aminoglycosides, 
the glycosidic linkage is α. Since 2-azido-2-deoxyglycopyranose donors rarely lead to 
clean formation of α-glycosides,31 we decided against having azides as protecting groups 
of amines. Mannose trichloroacetimidates, on the other hand, often times lead to rather 
stereoselective formation of α-disaccharides.32,33 Therefore, to accommodate all of the 
requirements for the glycosyl donor, we decided to design a mannose-based 
trichloroacetimidate with protecting groups at O-2 and O-6 orthogonal to protecting groups 
at O-3 and O-4. Since previous results showed that electron-withdrawing protecting groups 
on glycosyl trichloroacetimidates tend to slow down the glycosylation reactions,34 it was 
decided to use benzyl ethers as protecting groups on alcohols. In this case, p-
methoxybenzyl and benzyl ethers can be installed on mannose and removed under 
orthogonal to each other conditions.35  
The synthesis of trichloroacetimidate 4-34 commenced with full acetyl protection 
of mannose, followed by anomeric substitution with thiophenol in the presence of boron 
trifluoride, and deprotection of acetates with sodium methoxide. The resulting tetraol 4-28 
was protected with benzylidene acetal. The resulting acetal 4-29 was regioselectively 
benzylated through the formation of tin acetal.36 Next, 4,6-benzylidene functionality of 
4-30 could be reduced by borane/THF complex in the presence of dibutylboron triflate.37 
Resulting diol 4-31 was then protected with PMB groups. Finally, hydrolysis of the 
anomeric sulfide 4-32 in the presence of N-bromosuccinimide, followed by treatment with 
trichloroacetonitrile and catalytic amounts of DBU resulted in desired α-
trichloroacetimidate 4-34 with small amount of β anomer present (α/β = 10:1). 
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Scheme 4.14 Synthesis of glycosyl donor 
4.5 Glycosylation studies 
The investigation of glycosylative coupling between mannose trichloroacetimidate 
4-34 and diazido-2-deoxystreptamine 4-17 began with evaluation of chiral phosphoric 
acids and their derivatives (Figure 4.4). 
The glycosyl donor 4-34 (1.2 – 2 eq.) was combined with a glycosyl acceptor 16, 
activated 4Å MS, and 10 mol% of a catalyst, and the formation of glycosides was 
monitored by NMR. The studies commenced with evaluation of CF3-based chiral 
phosphoric acids (S)-4-16 and (R)-4-16. In both cases two glycosylated products were 
produced  (Table 4.1, entries 1–4) that upon careful NMR analysis were determined to be 
both α anomers.38 This result suggested formation of two regioisomeric products. 
Interestingly, 1:2 regioselectivity was observed when reaction was catalyzed with (S)-4-16 
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and it was reversed when the enantiomer of the catalyst was used. Unfortunately, the 
phosphoric acids with lacking the electron-withdrawing groups on their backbones failed 
to produce any glycosylated product by either promoting decomposition of the glycosyl 
donor to glycal (Table 4.1, entry 3), or by not catalyzing the reaction at all, (entries 6 – 8). 
Additionally, hydrogenation of the BINOL residue was found to negatively affect the 
regioselectivity (entry 9). While it became obvious that we were rather limited in the use 
of BINOL scaffolds, CPAs (S)-4-16 and (R)-4-16 provided two regioisomeric products 
with reverse selectivities when enantiomers of the CF3-based catalyst were used. This 
prompted us to investigate other strong chiral Brønsted acids such as nitrated CPA (S)-4-38 
(entry 10) or N-triflylphosphoramides 4-39 and 4-40 (entries 11 and 12). While nitration 
of a chiral phosphoric acid did not result in dramatic increase in the catalyst activity, use 
of chiral N-triflylphosphoramides resulted in formation of glycosylated products. 
Unfortunately, in the case of TRIP-based N-triflylphosphoramide 4-40 (entry 12), we 
observed unselective formation of all four products (α- and β- regioisomers). In the case of 
CF3-based N-triflylphosphoramide 4-39 though, the glycosylation resulted in slightly 
reduced regioselectivity. It is important to note that all glycosylation reactions were always 
accompanied by some formation of glycal, usually in the amount of 30% relative to 
glycosylated products. In addition, reaction with TMSOTf in DCM at -30 °C resulted in 
unselective formation of all four glycosylation products. These results prompted us to 
reinvestigate other chiral phosphoric acids before advancing to more complex and difficult 
to synthesize N-triflylphosphoramides.  
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Figure 4.4 Chiral Brønsted acids used in catalyst screening  
To improve the yield and regioselectivity, we performed evaluation of different 
parameters of the reaction conditions. Thus, glycosylation yields could be improved if 2 
equivalents of the glycosyl donor are used instead of 1.2. In addition, the use of the higher 
reaction temperature did not reduce the regioselectivity significantly, but resulted in a 
better conversion. The reaction conversions can be further improved if the reaction is 
refluxed for a prolonged period of time (2 equivalents of donor, 5 days at reflux in DCM 
give 50% conversion).  
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Table 4.1 Preliminary catalyst screening  
In addition to that, we also performed a preliminary solvent screening. The 
screening was executed with 1.2 equivalents of glycosyl donor, 10 mol% (R)-4-16, at 40oC. 
While glycosylation in toluene, CCl4 and hexanes was somewhat faster, regioselectivity 
dropped significantly either producing two α-regioisomers with 1:1 ratio (Table 4.2, entry 
2) or producing all α- and β-regioisomers (entries 4, 5). Reaction in THF was unacceptably 
slow, however surprisingly enough it produced a mixture of two α-regioisomers with 
reverse selectivity to what was expected. This phenomenon should be further investigated.   
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Table 4.2 Solvent screening  
Typical glycosylation reactions of trichloroacetimidate donors catalyzed with chiral 
phosphoric acids have rather fast reaction rates with reaction times ranging from 10 hours 
to 48 hours at temperatures below zero with 15 mol% catalyst loading.23,24 Reaction rates 
in case of 2-deoxystreptamine are surprisingly low. Hypothesizing that the glycosyl 
acceptor might be too sterically hindered, allyl and benzyl protected 2-deoxystreptamines 
(4-24 and 4-25 respectively) were tested under standard glycosylation conditions. Benzyl 
protected acceptor 4-24 was poorly soluble in DCM, leading to even slower glycosylation 
rates. Surprisingly, smaller in size allyl protected acceptor 4-25 was approximately as 
reactive as 4-17. Unfortunately, analysis of the mixture of glycosylation products was 
complicated by the overlapped anomeric 1H NMR peaks. While we could not interpret the 
outcomes of glycosylations with 4-24 and 4-25, we concluded that poor reactivity of 
glycosyl acceptor was not due to steric hindrance. We hypothesize that intramolecular 
hydrogen bonding in 2-deoxystreptamine donors is responsible for the low nucleophilicity 
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the of oxygen atoms. This hypothesis also explains poor reactivity observed in 
stereoselective acetalization reactions of 2-deoxystreptamine (vide supra). 
At this point more chiral phosphoric acids with electron-withdrawing became 
available. Thus, catalysts 4-42 – 4-44 were evaluated. As expected, SF5-based chiral 
phosphoric acid was more reactive and provided much higher conversion after two days 
than its CF3 analog. Additionally, the (S) enantiomer of 4-42 also provided higher 
selectivity, while (R) enantiomer on the contrary led to reduction of regioselectivity. This 
result suggests that in fact it is a matching/mismatching case between the chiral catalyst 
and chiral glycosyl donor. C6F5-Based chiral phosphoric acids 4-43 and 4-44 confirmed 
this hypothesis providing higher regioselectivities when (S) enantiomer of CPA was used 
and lower when the reaction was catalyzed with (R) CPA.  
Based on these data SF5-based CPA (S)-4-42 was chosen as the most selective and 
reactive catalyst and further optimization studies were done with it. The reaction can be 
run for 5 days providing the mixture of two glycosides with 1:5 selectivity and 88% 
conversion. Purification by column chromatography results in 78% yield of a glycosidic 
mixture of 1:4 – 1:3 with some amount of major regioisomer being lost along the way. A 
great care should be taken to purify the diglycosides from the glycal byproduct due to their 
extremely similar Rf values. Additionally, 4Å molecular sieves seem not to have any great 
effect on either selectivity of yield of the diglycosides.  
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Table 4.3 Additional catalyst screening 
4.6 NMR analysis of diglycosides 
In order to optimize the glycosylation reaction conditions, several additional 
experiments with higher concentration and catalyst loading were performed. Interestingly, 
when the reaction was performed in 0.5 M DCM, no previously observed glycosylation 
products 4-41ab were observed. Instead, another glycosylated product was isolated that 
had the same molecular weight and very similar 1H NMR pattern.  
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The anomeric configuration of the new diglycoside was determined by observing 
1JC-H coupling constant between the anomeric hydrogen and carbon. Typical coupling 
constants for α-mannosides are around 170 Hz, while coupling constants for β-mannosides 
are usually 160 Hz. All three isomeric diglycosides showed coupling constants above 170 
Hz (174.3 and 170.6 for typical products). This suggested formation of a third glycoside 
with α configuration at the anomeric position. Since glycosyl acceptor 4-17 contains only 
two free hydroxyl groups, we suspected that a rearrangement of either product or the 
starting material happened. Because 1H, COSY, HSQC and HMBC – based analysis of the 
three glycosides was inconclusive, acetylation of the residual hydroxyl group was 
performed. Using the HMBC and HSQC NMR techniques we were able to establish the 
connectivity between the mannose residue and 2-deoxystreptamine, while COSY 2D NMR 
analysis was used to determine connectivity of all groups on 2-deoxystreptamine residue. 
Thus, it was determined that the regularly observed glycosylation products have expected 
substitution pattern (4-45a and 4-45b). However, the new disaccharide 4-46 had a TBS 
group shifted from O-5 to the neighboring oxygen atom.  
Figure 4.5 Regioisomeric diglycosides 
This rearranged product (4-46) has been occasionally observed in up to 5% in 
reactions under normal reaction conditions. However, the attempts to optimize the TBS 
rearrangement unfortunately were unsuccessful. Additionally, refluxing glycosyl acceptor 
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4-17 or the mixture of 4-41a and 4-41b in the presence of 10 mol% of SF5-CPA (4-42) did 
not facilitate TBS shift nor change in regioisomeric ratio. 
In addition to 1J(C,H) coupling constants, 
3J(C,H) coupling constants can also be 
observed. Anomeric hydrogen of a conformationally rigid mannoside forms a dihedral 
angle with C-3 which corresponds to 180° in case of α-mannoside, and about 60° for β-
mannoside. Hence, Karplus relationship can be used for stereochemical assignment of the 
resulting disaccharide system39 (~8 Hz and 3 Hz 3J(C,H) coupling constants respectively).
40 
Direct measurement of 3J(C,H) using 
13C NMR is difficult due to low method sensitivity 
which is further complicated with low signal/noise ratio due to coupling of the signal. 
Analysis of carbohydrate molecules using such method is practically impossible due to the 
overlap or close arrangement of the 13C signals. 
HMBC experiment can be used for indirect observation of 3J(C,H) coupling 
constants. Modification of the pulse sequences in the HMBC experiment allows selective 
discrimination of the signals based on their (C,H) coupling constants. Since HMBC is 
measured in the magnitude mode, signal intensity directly correlates to the conformity 
between the indirect spin-spin coupling constants and the filter value. Standard HMBC 
pulse sequence includes two low pass filters which are responsible for filtration of signals 
that correspond to 1J(C,H) coupling constants (default setting 135 – 170 Hz) and inclusion 
of signals with 2-4J(C,H) coupling constants (default setting 8 Hz).
41 Thus, changing the pulse 
delay time, and analyzing the intensity of the cross peaks in HMBC spectrum one can 
obtain necessary information about stereochemical configuration of a molecule or its 
fragment.  
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The HMBC experiments were performed with the help of Dr. Iaroslav Khomutnyk. 
Gradient selected multiple bond correlation with adiabatic pulses (gHMBCAD) pulse 
sequence was used. The necessary sensitivity was achieved by using non-uniform sampling 
method (NUS). The experiments were run using two Jhnx filter values which correspond 
to 8 Hz (default) and 3 Hz (custom) coupling constants. The filter values were calculated 
using simplified formula Jhnx (ms) = ½ * J, and were equal to 62.5 and 166.7 ms 
correspondingly. Thus, when both 4-48a and 4-52 (perbenzylated 4-48b) were analyzed 
using gHMBCAD (62.5 ms) the crosspeaks between anomeric hydrogen and C-3 were 
observed, while the same experiment with 166.7 ms delay time showed no crosspeaks in 
that region (See Appendix C). This confirms the previously made assignment of 4-45a and 
4-45b both being α-mannosides. 
4.7 Synthesis of neamine 
In order to unambiguously assign the regio- and stereoselectivity of the resulting 
glycosides, we attempted the synthesis of synthetically modified neamine (Scheme 4.15) 
that has been previously reported, from glycosydic mixture of 4-41a and 4-41b.  
Scheme 4.15 Synthesis of perbenzyl-, perazidoneamine 
To access neamine 4-47, the 1:3 glycosidic mixture was subjected to TBAF in order 
to deprotect TBS group (Scheme 4.16). The resulting mixture of regioisomeric diols was 
separated and the major regioisomer was benzylated, followed by deprotection of PMB 
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groups with DDQ. Diol 4-49 was then tosylated and tosyl groups were inverted with 
sodium azide to yield 4-50. While having the desired molecular weight, 1H NMR of 
glycoside 4-50 did not match previously published spectra42 for natural neamine 4-47. The 
resulting NMR data suggests that (S)-4-42 leads to formation of two regioisomeric 
glycosides 4-41a and 4-41b with the ratio of 1:5 respectively. 
Scheme 4.16 Semisynthesis of neamine and structural assignment 
4.8 Conclusions 
In conclusion, we were able to show that chiral phosphoric acids facilitate 
desymmetrization of meso-diols via glycosylation reactions using mannose-α-
trichloroacetimidate 4-34. Chiral phosphoric acids typically produce a mixture of two α-
glycosides. While (R)-enantiomer typically leads to glycosylation of 2-deoxystreptamine 
derivative 4-17 with modest regioselectivities and a major regioisomer having 
glycosylation at O-4 (natural) of 2-deoxystreptamine, (S)-enantiomer favors glycosylation 
at O-6 with selectivities up to 1:5 (O-4 : O-6). This is the first report of desymmetrization 
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of meso-diols via glycosylation using chiral phosphoric acids as catalysts. This method has 
a potential to be applied for glycodiversification of 2-deoxystreptamine and synthesis of 
new aminoglycoside antibiotics. 
4.9 Experimental 
Unless otherwise stated, all reagents were purchased from commercial suppliers 
and used without purification. Toluene (PhMe), dichloromethane (CH2Cl2) and diethyl 
ether (Et2O) were filtered through a column (Innovative Technology PS-MD-5) of 
activated alumina under nitrogen atmosphere. All reactions were carried out under an 
atmosphere of nitrogen in flame- or oven-dried glassware with magnetic stirring. Reactions 
were cooled via external cooling baths: ice water (0 °C), Neslab Cryotrol CB-80 immersion 
cooler (0 to -60 °C) or Neslab Cryocool immersion cooler CC-100 II. Purification of the 
reactions mixtures was performed by flash chromatography using SiliCycleSiliaFlash P60 
(230-400 mesh) silica gel. All spectra were recorded on Varian vnmrs 700 (700 MHz), 
Varian vnmrs 500 (500 MHz), Varian MR400 (400 MHz), Varian Inova 500 (500 MHz) 
spectrometers and chemical shifts (δ) are reported in parts per million (ppm) and referenced 
to the 1H signal of the internal tetramethylsilane according to IUPAC recommendations.43 
Data are reported as (br = broad, s = singlet, d = doublet, t = triplet, q = quartet, qn = quintet, 
sext = sextet, m = multiplet; coupling constant(s) in Hz; integration). High resolution mass 
spectra (HRMS) were recorded on MicromassAutoSpecUltima or VG (Micromass) 70-
250-S Magnetic sector mass spectrometers in the University of Michigan mass 
spectrometry laboratory. Infrared (IR) spectra were recorded as thin films on NaCl plates 
on a Perkin Elmer Spectrum BX FT-IR spectrometer. Absorption peaks were reported in 
wavenumbers (cm-1).  
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Preparation of 2-deoxystreptamine derivatives 
2,2'-((1R,3S,4R,5r,6S)-4,5,6-trihydroxycyclo-
hexane-1,3-diyl)bis(5-(tert-butyl)isoindoline-1,3-dione) 
(4-9) 
100 mg (0.22 mmol) of 2-deoxystreptamine 
dihydrogenbromide44 was mixed with 100 mg (4.49 mmol) 
of 5-(tert-butyl)isobenzofuran-1,3-dione, followed by addition of pyridine (0.74 mL) and 
trimethylamine (0.14 mL). The resulting mixture was stirred at 100 °C overnight. The 
reaction mixture was cooled down, diluted with ethyl acetate and 1M solution of copper(II) 
sulfate. The product was extracted with ethyl acetate. The extracts were washed with 
copper(II) sulfate until light blue color of organic layer. Organic layer was dried with 
magnesium sulfate. The crude mixture was separated by column chromatography (3:2 
hexanes/ethyl acetate) (75.1 mg, 51% yield). 
The desired product was then suspended in methanol and to that ~1 mg of sodium hydride 
was added. The resulting suspension was stirred for 1 hour at room temperature. The 
mixture was then quenched with a drop of 1M HCl, and volatiles were removed in vacuo. 
Column chromatography (4:1 hexanes/ethyl acetate) resulted in 44.9 mg (74%) of white 
solid.  
IR (thin film, cm-1):3472 (br), 2964, 2254, 1770, 1714, 1622, 1431, 1365, 1222, 1110, 919, 
734. 1H NMR (500 MHz, CDCl3) δ 7.88 (s, 2H), 7.78-7.70 (m, 4H), 4.51 (t, J = 9.6 Hz, 
2H), 4.31 (m, 2H), 3.52 (t, J = 9.6 Hz, 1H), 3.18 (q, J = 12.8 Hz, 1H), 2.96 (s, 1H), 2.54 (s, 
2H), 1.90 (td, J = 4.2, 12.8 Hz, 1H), 1.37 (s, 18H). 13C NMR (175 MHz, CDCl3) δ 168.9, 
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168.5, 158.9,132.0, 131.2, 129.2, 123.4, 120.8, 78.0, 71.3, 51.3, 35.9, 31.3, 28.8; HRMS 
(ESI+) (m/z): [M+H]+ calcd for C30H35N2O7 535.2439, found 535.2439. 
(1R,2r,3S,4R,6S)-4,6-diazidocyclohexane-1,2,3-triol (4-7) 
2-Deoxystreptamine • 2HBr (324 mg, 1.0 mmol) was mixed together with 
potassium carbonate (650.9 mg, 2.4 mmol) and copper (II) sulfate pentahydrate (677.2 mg, 
4.9 mmol). The resulting mixture was suspended in 1:1 mixture of methanol and water (10 
mL) followed by careful addition of 1H-imidazole-1-sulfonyl azide • H2SO4 (650.9 mg, 
2.4 mmol). The resulting crude mixture was refluxed overnight, then solvents were 
evaporated in vacuo. Resulting crude product was suspended in methanol/dichloromethane 
mixture and solids were filtered off, when washed with methanol/dichloromethane and 
acetone. Resulting filtrate was concentrated, and the product was purified by column 
chromatography (1:1 dichloromethane/acetone). The procedure resulted in white 
crystalline solid (110 mg, 52% yield). The 1H NMR data coincide with the previous 
report.45 
1H NMR (400 MHz, CD3OD) δ 3.42-3.33 (m, 2H), 3.25-3.20 (m, 3H), 2.09 (dt, J = 13.0 
Hz, 4.5 Hz, 1H), 1.24 (q, J = 13.0 Hz, 1H). 
rac-(3aS,4R,5S,7R,7aS)-5,7-diazido-2,2-dimethylhexahydrobenzo[d]-
[1,3]dioxol-4-ol 
(1R,2r,3S,4R,6S)-4,6-diazidocyclohexane-1,2,3-triol (4-7) (50.0 mg, 
0.233 mmol) and diphenylphosphate (5.8 mg, 0.0233 mmol) were mixed in an oven-dried 
10 mL flask, and flushed with N2, to which DCM (5.8 mL) was added, followed by 2-
methoxypropene (26.8 μL, 0.280 mmol). The reaction was left overnight, then quenched 
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with trimethylamine, and volatiles were evaporated. Column chromatography (4:1 to 1:1 
hexanes/ethyl acetate) resulted in 41.5 mg of white solid. The 1H NMR data coincide with 
the previous report.46 Chiral assay: AD-H column, 90% hexanes, 10% isopropanol, 7.4 and 
9.2 min retention times.  
1H NMR (400 MHz, CDCl3) δ 3.79-3.61 (m, 2H), 3.45-3.36 (m, 3H), 2.55 (s, 1H), 2.34 
(dt, J = 13.8, 5.1 Hz, 1H), 1.50 (q, J = 13.8 Hz, 1H), 1.47 (s, 6H).  
(1R,2r,3S,4R,6S)-4,6-diazido-2-((tert-butyldimethylsilyl)oxy)-
cyclohexane-1,3-diol (4-17) 
(1R,2r,3S,4R,6S)-4,6-diazidocyclohexane-1,2,3-triol (4-7) (0.770 mg, 
3.27 mmol) was dissolved in 33 mL of dry THF under nitrogen, and cooled 
down to 0 °C. To that solution 2,6-lutidine (1.51 mL, 13.1 mmol) and TBSOTf (1.66 mL, 
7.2 mmol) were added dropwise. The reaction mixture was warmed up to room temperature 
and quenched with methanol after 3 hours. Column chromatography (10:1 hexanes/ethyl 
acetate) resulted in 964 mg of white crystalline material. The 1H NMR data coincide with 
the previous report. 
1H NMR (400 MHz, C6D6) δ 2.97 (t, J = 9.7 Hz, 1H), 2.75 (td, J = 9.7, 3.6 Hz, 2H), 2.52 
(ddd, J = 12.5, 9.7, 4.5 Hz, 2H), 1.42 (td, J = 12.5, 4.5 Hz, 1H), 0.93 (s, 9H), 0.81 (q, J = 
12.5 Hz, 1H), 0.11 (s, 6H). 
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Preparation of mannose trichloroacetimidate 
(2R,3R,4S,5S,6R)-3,4-bis(benzyloxy)-5-((4-methoxybenzyl)oxy)-2-
(((4-methoxybenzyl)oxy)methyl)-6-(phenylthio)tetrahydro-2H-
pyran (4-32) 
An oven dried and N2 flushed 250 mL round bottom flask was charged with 783 mg (1.73 
mmol) of (2R,3S,4R,5R,6R)-4,5-bis(benzyloxy)-6-(hydroxymethyl)-2-(phenylthio)tetra-
hydro-2H-pyran-3-ol (4-31) and anhydrous DMF (15 mL). This mixture was cooled to 0 
°C and sodium hydride (60%, 280 mg, 6.921 mmol) was added portion wise over 20 min 
period. When the evolution if H2 has stopped, p-methoxybenzyl chloride (0.82 mL, 6.055 
mmol) was added dropwise followed by TBAI (64 mg, 0.173 mmol). The reaction was 
stirred at room temperature overnight. Then the reaction was cooled to 0 °C and 3 mL of 
methanol was added dropwise, followed by addition of 50 mL of water. Organics were 
extracted with diethyl ether. Organic layer was washed with water, and then dried with 
magnesium sulfate. The product was purified by column chromatography (5:1 to 3:1 
hexanes/ethyl acetate) resulting in 1.04 g (87%) of colorless oil. 
IR (thin film, cm-1): 3061, 3001, 293, 2865, 2059, 1884, 1756, 1612, 1585, 1248, 1097, 
1034, 820, 698. 1H NMR (700 MHz, CDCl3) δ 7.45-7.42 (m, 2H), 7.35-7.33 (m, 2H), 7.30-
7.23 (m, 13H), 7.18 (d, J = 7.1 Hz, 2H), 6.81 (t, J = 8.2 Hz, 4H), 5.58 (d, J = 1.5 Hz, 1H), 
4.89 (d, J = 10.7 Hz, 1H), 4.67 (d, J = 11.7 Hz, 1H), 4.6-4.54 (m, 4H), 4.50 (d, J = 10.7 
Hz, 1H), 4.41 (d, J = 11.7 Hz, 1H), 4.25 (ddd, J = 9.7, 5.0, 1.6, 1H), 4.04 (t, J = 9.7Hz, 
1H), 3.99-3.97 (m, 1H), 3.85-3.80 (m, 2H), 3.78 (s, 3H), 3.77 (s, 3H), 3.70 (dd, J = 11.0, 
1.6 Hz, 1H). 13C NMR (175 MHz, CDCl3) δ 159.4, 159.2, 138.6, 138.4, 134.6, 131.7, 
130.6, 130.0, 129.7, 129.6, 129.1, 128.5, 128.4, 128.1, 127.9, 127.8, 127.7, 127.4, 113.9, 
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113.8, 85.9, 80.2, 75.7, 75.3, 75.1, 73.0, 72.9, 72.1, 71.6, 68.8, 55.4, 55.3, 31.7. HRMS 
(ESI+) (m/z): [M+Na]+ calcd for C26H28O5SNa 710.3146, found 710.3122. 
(2R,3S,4S,5R,6R)-4,5-bis(benzyloxy)-3-((4-methoxybenzyl)oxy)-
6-(((4-methoxybenzyl)oxy)methyl)tetrahydro-2H-pyran-2-yl 
2,2,2-trichloroacetimidate (4-34) 
A 250 mL round bottom flask was charged with (2R,3R,4S,5S,6R)-
3,4-bis(benzyloxy)-5-((4-methoxybenzyl)oxy)-2-(((4-methoxy-benzyl)oxy)methyl)-6-
(phenylthio)tetrahydro-2H-pyran (4-32) and dissolved in a 9:1 mixture of acetone and 
water. This mixture was cooled to 0 °C and NBS (540 mg, 3.01 mmol) was added. The 
reaction mixture was monitored by TLC and upon reaction completion it was quenched 
with solid sodium carbonate. Volatiles were removed in vacuo and organics were extracted 
with ethyl acetate. The combined organic layer was washed with saturated sodium 
bicarbonate, then brine, then dried with magnesium sulfate. The crude product was purified 
by column chromatography (2:1 to 1:1 hexanes/ethyl acetate) resulting in 700 mg (81%) 
of colorless oil (α/β = 2:1).  
An oven dried and nitrogen flushed 250 mL round bottom flask was charged with mannose 
from the previous step (4-33) (700 mg, 1.165 mmol) and dry DCM (7.8 mL). This mixture 
was cooled to 0 °C and trichloroacetonitrile (0.35 mL, 3.49 mmol) was added, followed by 
DBU (87 μL, 0.583 mmol). The resulting reaction mixture was warmed to room 
temperature and stirred for 6 hours. The crude product was purified by column 
chromatography (5:1 to 3:1 hexanes/ethyl acetate) resulting in the pure product as pale-
yellow oil (0.529 mg, 61%, α/β = 20:1). 
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IR (thin film, cm-1): 3473, 2928, 1723, 1612, 1514, 1454, 1363, 1249, 1108, 1035, 836, 
698. 1H NMR (700 MHz, C6D6, α only) δ 8.47 (s, 1H), 7.33-7.28 (m, 4H), 7.26 (d, J = 7.4 
Hz, 2H), 7.22 (d, J = 8.9 Hz, 2H), 7.16-7.11 (m, 4H), 7.08 (d, 7.0 Hz, 2H), 6.79-6.72 (m, 
5H), 5.00 (d, J = 11.0 Hz, 1H), 4.65 (d, J = 11.0 Hz, 1H), 4.61-4.57 (m, 3H), 4.57-4.51 (m, 
3H), 4.39 (d, J = 11.7 Hz, 1H), 4.27 (dd, J = 9.6, 3.4 Hz, 1H), 4.16 (dd, J = 9.6, 3.1), 4.03 
(t, J = 2.5 Hz, 1H), 3.89 (dd, J = 11.4, 4.3 Hz, 1H), 3.73 (d, J = 11.4 Hz, 1H), 3.30 (s, 3H), 
3.29 (s, 3H). 13C NMR (175 MHz, C6D6, α only) δ 160.6, 159.8, 159.6, 139.3, 139.0, 131.1, 
130.6, 129.8, 129.7, 128.5, 128.4, 128.3, 128.2, 128.0, 127.7, 127.6, 114.1, 114.0, 96.9, 
79.7, 76.0, 75.4, 74.8, 73.9, 73.3, 72.7, 72.3, 68.8, 54.7. (ESI+) (m/z): [M+NH4]
+ calcd for 
C38H44Cl3N2O8 761.2158, found 761.2152. 
Glycosylation studies 
A flame-dried 4 mL vial was charged with mannose trichloroacetimidate 4-34 (175.6 mg, 
0.236 mmol), 2-deoxystreptamine 4-17 (38.7 mg, 0.118 mmol), 4 Å MS (~100 mg), and 
(S)-SF5-CPA catalyst (11.8 mg, 0.0236 mmol). The resulting mixture was flushed with 
nitrogen, then dry dichloromethane (0.59 mL) was added. The resulting mixture was 
refluxed for 5 days, then quenched with triethylamine. Crude 1H NMR showed 88% 
conversion with 1:5 selectivity. The mixture was purified by column chromatography (9:1 
hexanes/ethyl acetate). Purification resulted in some mixed fractions of glycal with 
glycosylated product and fractions of pure glycosylation products (1:4 regioselectivity). 
119 
 
All fractions containing glycal and glycosylation products were combined and used in the 
next deprotection step. 78% yield (colorless oil). 
IR (thin film, cm-1): 3478, 3031, 2933, 2857, 1612, 1514, 1248, 1095, 1037, 837. 1H NMR 
(700 MHz, C6D6, 4-41a only) δ 7.44 (d, J = 8.5 Hz, 2H), 7.39 (d, J = 8.5 Hz, 2H), 7.30 (d, 
J = 7.5 Hz, 2H), 7.25 (d, J = 8.5 Hz, 2H), 7.21-7.17 (m, 3H), 7.14-7.05 (m, 3H), 6.82 (d, J 
= 8.5 Hz, 2H), 6.76 (d, J = 8.5 Hz, 2H), 5.70 (d, J = 1.6 Hz, 1H), 5.16 (d, J = 11.0 Hz, 1H), 
5.01 (d, J = 11.7 Hz, 2H), 4.85 (d, J = 11.9 Hz, 1H), 4.79 (d, J = 11.0 Hz, 1H), 4.76 (d, J = 
11.9 Hz, 1H), 4.67 (d, J = 11.4 Hz, 1H), 4.62 (d, J = 11.4 Hz, 1H), 4.55 (dd, J = 9.5, 5.0), 
4.45 (d, J = 11.7 Hz, 1H), 4.34 (dd, J = 9.5, 2.4 Hz, 1H), 4.22 (t, J = 2.4 Hz, 1H), 3.96 (dd, 
J = 11.0, 4.8, 1H), 3.89 (dd, J = 11.0, 1.4 Hz, 1H), 3.50 (t, J = 9.5 Hz, 1H), 3.32 (s, 3H), 
3.315 (s, 3H), 3.23 (t, J = 8.9 Hz, 1H), 2.68 (dd, J = 9.5, 4.0 Hz, 1H), 2.47 (ddd, J = 12.3, 
9.7, 4.6 Hz, 1H), 1.81(d, J = 3.9 Hz, 1H), 1.49 (dt, J = 12.3, 4.6, 1H), 1.0 (s, 9H), 0.19 (s, 
3H), 0.18 (s, 3H). 1H NMR (700 MHz, C6D6, 4-41b only) δ 7.40 (t, J = 8.0 Hz, 4H), 7.34 
(d, J = 7.3 Hz, 2H), 7.30-7.25 (m, 3H), 7.25-7.18 (m, 2H), 7.12-7.07 (m, 3H), 6.82 (d, J = 
8.3 Hz, 2H), 6.78 (d, J = 8.3 Hz, 2H), 5.64 (d, J = 1.7 Hz, 1H), 5.02 (d, J = 10.9 Hz, 1H), 
4.85 (d, J = 12.5 Hz, 1H), 4.78 (d, J = 10.9 Hz, 1H), 4.75 (d, J = 5.5 Hz, 1H), 4.68 (d, J = 
11.7 Hz, 1H), 4.62 (d, J = 10.9 Hz, 1H), 4.60 (d, J = 10.9 Hz, 1H), 4.46-4.38 (m, 3H), 4.29-
4.26 (m, 2H), 3.92 (dd, J = 10.1, 4.7, 1H), 3.84 (d, J = 10.9 Hz, 1H), 3.33 (s, 3H), 3.31 (s, 
3H), 3.17 (dd, J = 12.5, 8.1 Hz, 2H), 2.79 (dt, J = 12.2, 9.5, 4.2, 1H), 2.49 (ddd, J = 12.5, 
9.8, 4.8 Hz, 1H), 1.90 (d, J = 3.6 Hz, 1H), 1.45 (dt, J = 12.5, 4.5 Hz, 1H), 1.02 (s, 9H), 0.88 
(q, J = 12.7 Hz, 1H), 0.33 (s, 3H), 0.21 (s, 3H). 13C NMR (175 MHz, C6D6) δ 159.9, 159.8, 
159.7, 159.6, 139.7, 139.6, 139.5, 139.4, 131.4, 131.3, 131.1, 131.0, 130.1, 129.7 (3C), 
128.7, 128.6, 128.5, 128.4, 128.0, 127.8, 127.7 (4C), 127.5 (2C), 114.2, 114.1 (2C), 114.0, 
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99.8 (J = 174.3 Hz), 99.0 (J = 170.6 Hz), 81.5, 80.0, 77.9, 77.8, 77.1, 76.8, 76.6, 75.9, 75.7, 
75.4, 75.1, 74.9, 74.8, 74.1, 73.9, 73.4, 73.3, 73.2, 73.1, 72.4, 69.9, 69.6, 60.8, 60.7, 60.4, 
60.0, 54.8, 54.7, 32.1, 31.8, 26.5, 26.4, 18.7, 18.6, -2.5, -3.1, -3.2, -3.3. (ESI+) (m/z): 
[M+NH4]
+ calcd for C48H62N6O10SiNH4 928.4635, found 928.4631. 
Characterization data for 4-51 
IR (thin film, cm-1): 3475, 3036, 1620, 1565, 1265, 1084, 1047, 
831. 1H NMR (500 MHz, C6D6) δ 7.41 (d, J = 7.2 Hz, 2H), 7.34 
(d, J = 8.3 Hz, 2H), 7.23-7.14 (m, 5H), 7.15-7.06 (m, 5H), 6.81 (d, J = 8.7 Hz, 2H), 6.77 
(d, J = 8.3 Hz, 2H), 5.05 (d, J = 1.6 Hz, 1H), 4.94 (d, J = 11.4 Hz, 1H), 4.73-4.60 (m, 5H), 
4.51-4.38 (m, 3H), 3.74 (dd, J = 10.0, 1.6 Hz, 1H), 3.56 (dd, J = 9.7, 8.1 Hz, 1H), 3.30 (d, 
J = 2.1 Hz, 6H), 3.23-3.14 (m, 2H), 2.86 (t, J = 8.5 Hz, 1H), 2.73 (ddd, J = 12.9, 8.8, 4.4 
Hz, 1H), 2.59 (ddd, J = 12.9, 9.7, 4.4 Hz, 1H), 1.50 (dt, J = 13.2, 4.4 Hz, 1H), 0.87 (q, J = 
12.7 Hz, 1H). 13C NMR (500 MHz, C6D6) δ 160.0, 159.9, 139.1 (2C), 130.6, 130.4, 130.0, 
128.7, 128.5, 128.3, 127.7, 114.2, 101.1 (J = 170.6 Hz), 89.1, 80.3, 77.1, 75.6, 75.2, 75.0, 
73.5, 73.1 (2C), 72.0, 69.0, 62.3, 59.7, 54.8, 54.7, 32.1, 27.2, 26.3, 18.8, -3.4, -4.5. (ESI+) 
(m/z): [M+NH4]
+ calcd for C48H62N6O10SiNH4 928.4635, found 928.4635. 
 
The resulting mixture 4-41ab isolated from the previous reaction 
was mixed with ~50 mg of 4Å MS, flushed with nitrogen, and 
then dissolved in 3.0 mL dry THF. The reaction was cooled down 
to 0 °C, and 0.11 mL (0.111 mL) of TBAF (1.0 M) was added. The reaction was warmed 
up to room temperature and was stirred overnight. Then the reaction was quenched with 
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NaHCO3 (sat.) and extracted with ethyl acetate. Organics were washed with brine/water 
(1:1) x2, then brine. Extracts were dried with magnesium sulfate, filtered and evaporated. 
The mixture was purified by column chromatography (3:1 to 2:1 hexanes/ethyl acetate). 
The procedure yielded of 36.5 mg (66%) of major isomer (4-48b) and 10.9 mg (59%) of 
minor isomer (4-48a). The major isomer was then used in the next steps.  
4-48a IR (thin film, cm-1): 3428, 2926, 1720, 1612, 1586, 1514, 1454, 1364, 1250, 1104, 
1033, 818, 699. 1H NMR (500 MHz, C6D6) δ 7.39 (d, J = 7.5 Hz, 2H), 7.35 (d, J = 7.5, 
2H), 7.27-7.12 (m, 8H), 7.12-7.06(m, 2H), 6.79 (d, J = 8.3 Hz, 2H), 5.48 (d, J = 1.3 Hz, 
1H), 4.95, (d, J = 11.7 Hz, 1H), 4.82 (d, J = 11.7 Hz, 1H), 4.70 (d, J = 11.7 Hz, 1H), 4.56 
(s, 2H), 4.54-4.46 (m, 2H), 4.40 (d, J = 11.0 Hz, 1H), 4.27 (d, J = 11.0 Hz, 1H), 4.20-4.12 
(m, 3H), 3.88 (dd, J = 10.0, 1.3 Hz, 1H), 3.71 (dd, J = 10.0, 7.3 Hz, 1H), 3.42 (t, J = 10.0 
Hz, 1H), 3.32 (s, 3H), 3.31-3.26 (m, 1H), 3.29 (s, 3H), 2.98 (t, J = 9.4 Hz, 1H), 2.70-2.58 
(m, 2H), 1.51 (dt, J = 12.8, 4.7 Hz, 1H), 0.91 (q, J = 12.8 Hz, 1H). 13C NMR (125 MHz, 
C6D6) δ 160.0 (2C), 139.3, 139.2, 130.9, 130.2, 130.1, 128.6, 128.5, 128.0, 127.9, 127.8, 
127.7, 114.2 (2C), 96.4 (J = 170.6 Hz), 80.9, 80.3, 76.6, 75.8, 75.7, 74.8, 73.4, 73.2, 72.9, 
72.4, 70.1, 59.9, 58.0, 54.8, 32.4. (ESI+) (m/z): [M+NH4]
+ calcd for C42H52N7O10 
814.3770, found 814.3769. 
4-48b IR (thin film, cm-1): 3469, 2654, 1702, 1613, 1586, 1369, 1256, 1109, 1033, 816, 
689, 658. 1H NMR (500 MHz, C6D6) δ 7.42 (d, J = 7.4 Hz, 2H), 7.34 (d, J = 8.5 Hz, 2H), 
7.25 (d, J = 7.4 Hz, 2H), 7.23-7.17 (5H), 7.15-7.07 (m, 3H), 6.82 (dd, J = 8.5, 6.6 Hz, 4H), 
5.04 (d, J = 1.6 Hz, 1H), 4.99 (d, J = 11.1 Hz, 1H), 4.95 (d, J = 3.1 Hz, 1H), 4.71 (d, J = 
11.8 Hz, 1H), 4.68 (d, J = 11.5 Hz, 1H), 4.63 (d, J = 8.1 Hz, 1H), 4.61 (d, J = 8.1 Hz, 1H), 
4.45 (d, J = 11.5 Hz, 1H), 4.27-4.19 (m, 3H), 4.15 (t, J = 2.0 Hz, 1H), 4.09 (dd, J = 9.3, 3.3 
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Hz, 1H), 4.01 (t, J = 9.3 Hz, 1H), 3.81 (dd, J = 9.7, 1.6 Hz, 1H), 3.3 (t, J = 9.0 Hz, 1H), 
3.35 (s, 3H), 3.33-3.27 (m, 1H), 3.30 (s, 3H), 3.18 (t, J = 9.7 Hz, 1H), 3.06 (td, J = 8.8, 2.8 
Hz, 1H), 2.95-2.83 (m, 3H), 2.56 (ddd, J = 12.7, 9.5, 4.6, 1H), 1.50 (dt, J = 13.2, 4.6, 1H), 
0.89 (q, J = 13.2 Hz, 1H). 13C NMR (125 MHz, C6D6) δ 160.1, 160.0, 139.1, 139.0, 130.6, 
130.1, 130.0, 129.9, 128.7, 128.6, 128.0, 127.9, 127.8, 114.2, 114.1, 100.4 (J = 169.4 Hz), 
88.1, 80.5, 76.4, 75.6, 75.2, 75.1 (2C), 73.4, 73.3, 73.0, 71.9, 70.0, 59.6, 54.9, 54.8, 32.2. 
(ESI+) (m/z): [M+NH4]
+ calcd for C42H52N7O10 814.3770, found 814.3767. 
The major diol (30.6 mg, 0.0384 mmol) isolated from the 
previous reaction (4-48b) was dissolved in dry DMF (0.38 mL). 
To that 6.1 mg of sodium hydride was added (60%, 0.154 mmol), 
and the reaction mixture was flushed with nitrogen. To that 22.8 μL (0.192 mmol) of benzyl 
bromide was added. The resulting mixture was stirred at 40 °C overnight. Reaction was 
then diluted with DCM, and aqueous ammonia chloride was added. Organics were 
extracted with DCM, and then washed with brine and dried with magnesium sulfate. 
Column chromatography (9:1 to 4:1 hexanes/ethyl acetate) resulted in 30.6 mg of colorless 
oil. 
1H NMR (400 MHz, C6D6) δ 7.45 (d, J = 7.2 Hz, 2H), 7.41-7.33 (m, 6H), 7.26-7.17 (m, 
10H), 7.14-7.04 (m, 6H), 6.81 (d, J = 8.3 Hz, 2H), 6.75 (d, J = 8.3 Hz, 2H), 5.68 (s, 1H), 
5.01 (d, J = 11.3 Hz, 1H), 4.84 (d, J = 5.7 Hz, 2H), 4.80 (d, J = 3.4 Hz, 2H), 4.75 (d, J = 
10.8 Hz, 1H), 4.70 (d, J = 10.8 Hz, 1H), 4.66 (s, 2H), 4.63 (d, J = 8.6 Hz, 1H), 4.60 (d, J = 
8.6 Hz, 1H), 4.48 (t, J = 9.5 Hz, 1H), 4.38( d, J = 11.7 Hz, 1H), 4.34-4.27 (m, 1H), 4.18-
4.12 (m, 2H), 3.71-3.63 (m, 2H), 3.39 (t, J = 9.4 Hz, 1H), 3.33 (s, 3H), 3.30 (s, 3H), 3.04 
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(t, J = 9.4 Hz, 1H), 2.95 (t, J = 9.4 Hz, 1H), 2.72-2.59 (m, 2H), 1.44(dt, J = 13.1, 4.3 Hz, 
1H), 0.84 (q, J = 13.1 Hz, 1H). 
Compound 4-52 (45.8 mg, 0.0469 mmol) was mixed together 
with DDQ (21.3 mg, 0.0937 mmol), then 0.32 mL of DCM was 
added along with 1 drop of water. The mixture was stirred at 
room temperature for 1.5 hours. Then the reaction was quenched 
with saturated sodium bicarbonate, and extracted with DCM. Organics were washed with 
saturated sodium bicarbonate, brine, dried with magnesium sulfate. Column 
chromatography (4:1 to 3:2 hexanes/ethyl acetate resulted in 23.1 mg (67%) of colorless 
oil. 
1H NMR (400 MHz, C6D6) δ 7.36 (d, J = 7.5 Hz, 2H), 7.33 (d, J = 7.5 Hz, 2H), 7.26-7.21 
(m, 4H), 7.20-7.04 (m, 12H), 5.65 (s, 1H), 4.88 (d, J = 11.3 Hz, 1H), 4.84 (d, J = 11.0 Hz, 
1H), 4.72 (d, J = 11.3 Hz, 1H), 4.69 (s, 2H), 4.65 (d, J = 11.3 Hz, 1H), 4.53 (s, 2H), 4.29 
(s, 1H), 4.16-4.05 (m, 2H), 4.97 (dd, J = 8.6, 3.2 Hz, 1H), 3.73 (d, J = 12.2 Hz, 1H), 3.66-
3.57 (m, 1H), 3.28 (t, J = 9.5 Hz, 1H), 2.99 (t, J = 9.3 Hz, 1H), 2.93 (d, J = 9.3 Hz, 1H), 
2.72-2.55 (m, 3H), 1.44 (dt, J = 12.9, 4.1 Hz, 1H), 0.85 (q, J = 12.9 Hz, 1H). 
Compound 4-49 (23.1 mg, 0.0314 mmol) was dissolved in 0.17 
mL of dry DCM, and cooled down to -15 °C under nitrogen. To 
this mixture 12.6 μL of pyridine (0.157 mmol) was added, 
followed by 21.1 μL of trifluoromethanesulfonic anhydride (0.125 mmol). The resulting 
mixture was stirred at the same temperature for 10 minutes. Then the mixture was diluted 
with DCM and water. Organics were extracted with DCM. Extracts were washed with 
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saturated sodium bicarbonate and water, dried with magnesium sulfate. The crude material 
was used in the next step without purification. (30.1 mg, 96 % yield). 
1H NMR (500 MHz, C6D6) δ 7.38 (t, J = 7.0 Hz, 3H), 7.24 (d, J = 7.5 Hz, 2H), 7.15-7.07 
(m, 10H), 7.07-7.03 (m 5H), 5.67 (d, J = 1.7 Hz, 1H), 5.39 (t, J = 2.2 Hz, 1H), 4.92 (d, J = 
11.2 Hz, 1H), 4.77-4.66 (m, 4H), 4.62 (d, J = 11.5 Hz, 1H), 4.39 (dd, J = 11.2, 3.9 Hz, 2H), 
4.19 (dd, J = 10.9, 1.7, 1H), 4.16 (d, J = 11.2 Hz, 1H), 4.11 (ddd, J = 10.2, 4.6, 1.7 Hz, 
1H), 3.93 (dd, J = 9.3, 2.8 Hz, 1H), 3.79 (dd, J = 11.2, 4.6 Hz, 1H), 7.37 (t, J = 9.7 Hz, 
1H), 3.07 (t, J = 9.7 Hz, 1H), 3.0-2.87 (m, 3H), 2.66-2.54 (m, 2H), 1.39 (dt, J = 12.9, 4.8 
Hz, 1H), 0.76 (q, J = 12.9 Hz, 1H). 
The resulting triflate 4-53 (30.1 mg, 0.0301 mmol) was dissolved 
in dry DMF, flushed with nitrogen. To that sodium azide (7.8 
mg, 0.120 mmol). The mixture was stirred at 40 °C for 4 hours. 
Then in was diluted with DCM and water. The organics were extracted with DCM, then 
washed with brine/water (1:1), and then brine. Organic layer was dried with magnesium 
sulfate. The product was purified by column chromatography (4:1 hexanes/ethyl acetate). 
The procedure yielded 3 mg of the desired product.  
4-50 IR (thin film, cm-1): 2924, 2103, 1722, 1454, 1361, 1260, 1124, 739, 697. 1H NMR 
(700 MHz, CDCl3) δ 7.37-7.31 (m, 7H), 7.31-7.27 (m, 8H), 7.20 (d, J = 7.3 Hz, 1H), 7.17-
7.13 (m, 4H), 5.56 (d, J = 3.7 Hz, 1H), 5.30 (s, 1H), 5.02 (d, J = 11.0 Hz, 1H), 4.90-4.86 
(m, 3H), 4.84 (d, J = 10.6 Hz, 1H), 4.79 (d, J = 11.5 Hz, 1H), 4.68 (d, J = 11.5 Hz, 1H), 
4.47 (d, J = 11.5 Hz, 1H), 4.00-3.97 (m, 1H), 3.87 (t, J = 9.7 Hz, 1H), 3.60-3.55 (m, 1H), 
3.55-3.47 (m, 4H), 3.46-3.43 (m, 2H), 3.40 (dd, J = 10.3, 3.7 Hz, 1H), 3.05 (dd, J = 13.4, 
125 
 
2.1 Hz, 1H), 2.68 (dd, J = 13.4, 3.4 Hz, 1H), 2.31 (dt, J = 13.2, 4.5 Hz, 1H), 1.50 (q, J = 
13.2 Hz, 1H). 13C NMR (175 MHz, CDCl3) δ 138.1, 137.8, 137.6, 137.3, 128.6, 128.5 (2C), 
128.4, 128.2 (2C), 128.1, 127.9, 127.8, 127.7, 127.4, 97.6, 84.8, 81.9, 80.1, 78.6 (2C), 76.2, 
76.0, 75.6, 75.1, 70.5, 63.6, 61.6, 60.5, 50.4, 32.8, 29.8. (ESI+) (m/z): [M+Na]+ calcd for 
C40H42N12O6Na 809.3242, found 809.3232. 
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Thiophosphoramide Catalyst 2-10 
Energy (kcal/mol): -2273472.26 
Job type: Single point.  
Method: RB3LYP 
Basis set: 6-31+G* 
Number of shells: 261 
Number of basis functions: 925 
Multiplicity: 1 
Coordinates (XYZ): 
 X  Y  Z 
P       -0.054160      0.009696     -0.189104 
C        2.359336     -4.915996      0.058476 
C        1.447459     -2.332969     -0.603251 
C        3.146376     -4.059166     -0.714679 
C        1.113154     -4.464877      0.491034 
C        0.648562     -3.187890      0.165880 
C        2.704656     -2.778032     -1.038428 
H       -0.327224     -2.868146      0.514556 
H        3.335131     -2.123795     -1.634109 
C       -4.468079      1.312396      0.546018 
C       -3.874591     -0.889114     -1.041591 
C       -3.141999      1.046840      0.209496 
C       -5.510446      0.497843      0.094649 
C       -5.198292     -0.599878     -0.704581 
131 
 
C       -2.836358     -0.064459     -0.592187 
H       -2.355444      1.697811      0.571914 
H       -6.538528      0.719248      0.353674 
H       -3.652505     -1.755958     -1.658715 
C        3.352900      3.100822      0.540394 
C        1.134808      3.771585     -0.992777 
C        3.199705      4.418648      0.110055 
C        2.420406      2.115252      0.210647 
C        1.299119      2.447375     -0.561318 
C        2.081254      4.740038     -0.661557 
H        3.929937      5.175760      0.367739 
H        2.566823      1.101499      0.565327 
H        0.265380      4.046286     -1.584084 
H        2.705760     -5.911041      0.308212 
N        1.010518     -1.050273     -0.997629 
H        1.611907     -0.583006     -1.668944 
N       -1.515469     -0.348888     -0.997127 
H       -1.426644     -1.108211     -1.665144 
N        0.348374      1.482031     -0.952097 
H       -0.358220      1.810150     -1.602496 
C        0.223802     -5.354353      1.327080 
C        4.523171     -4.495713     -1.154227 
C       -6.285685     -1.504636     -1.231319 
C       -4.789312      2.480919      1.447515 
C        1.901285      6.142009     -1.190830 
132 
 
C        4.529729      2.711399      1.403730 
F       -5.964778      3.064932      1.111939 
F       -4.900023      2.094824      2.743620 
F       -3.835993      3.441918      1.402666 
F       -7.515251     -1.128024     -0.821119 
F       -6.103386     -2.790321     -0.836088 
F       -6.302597     -1.520320     -2.590920 
F        0.701802     -6.614420      1.426227 
F        0.081138     -4.879336      2.588899 
F       -1.027117     -5.438976      0.802281 
F        4.859821     -3.973518     -2.360292 
F        4.624470     -5.840531     -1.253918 
F        5.476562     -4.091913     -0.275394 
F        0.604128      6.535116     -1.150711 
F        2.293480      6.237039     -2.490231 
F        2.620248      7.050389     -0.496100 
F        5.500960      3.651330      1.403453 
F        5.093426      1.549644      0.983239 
F        4.159927      2.518729      2.694189 
S       -0.064692     -0.034590      1.746971 
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Thiophosphoramide Catalyst 2-10 + Mesylate 
Energy (kcal/mol): -2690086.83 
Job type: Single point. 
Method: RB3LYP 
Basis set: 6-31+G* 
Number of shells: 293 
Number of basis functions: 1030 
Charge : -1  
Multiplicity: 1 
Coordinates (XYZ): 
 X  Y  Z 
P       -0.010625      0.013533     -0.740398 
C        1.677731     -5.232520     -0.468896 
C        0.420573     -2.712024     -0.206436 
C        0.806370     -4.974540      0.592557 
C        1.913017     -4.210784     -1.389866 
C        1.298570     -2.962082     -1.274564 
C        0.187630     -3.734832      0.733005 
H        1.495461     -2.192254     -2.010312 
H       -0.468465     -3.538845      1.575176 
C        2.786153      3.745765     -1.280467 
C        3.073421      2.035209      0.890391 
C        1.995327      2.596226     -1.205134 
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C        3.724828      4.054411     -0.296411 
C        3.855216      3.181874      0.788373 
C        2.135044      1.723613     -0.114087 
H        1.280144      2.376130     -1.987910 
H        4.333707      4.948522     -0.367604 
H        3.164586      1.379268      1.749923 
C       -4.618481      0.660922     -1.445585 
C       -3.359870      1.558378      0.862481 
C       -5.393704      1.210925     -0.423859 
C       -3.229448      0.559428     -1.339243 
C       -2.583332      1.009287     -0.176112 
C       -4.742726      1.659017      0.728551 
H       -6.469888      1.286392     -0.520410 
H       -2.649395      0.140951     -2.152858 
H       -2.866699      1.885653      1.772846 
H        2.159705     -6.197610     -0.572395 
N       -0.257761     -1.500165     -0.016362 
H       -0.698434     -1.431682      0.914235 
N        1.404256      0.537191      0.035752 
H        1.522747      0.107367      0.967375 
N       -1.193258      0.969859      0.011178 
H       -0.910978      1.256915      0.961997 
C        2.812096     -4.488895     -2.565982 
C        0.581688     -6.036600      1.635599 
C        4.835770      3.529598      1.876476 
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C        2.672611      4.646328     -2.482375 
C       -5.554033      2.195305      1.878042 
C       -5.286490      0.218866     -2.721277 
F        1.462470      4.576438     -3.083078 
F        2.882651      5.953112     -2.166103 
F        3.597109      4.338434     -3.437400 
F        6.037047      3.925541      1.368585 
F        5.084411      2.498192      2.715332 
F        4.399001      4.564903      2.648686 
F        2.147795     -5.118716     -3.577446 
F        3.347936     -3.366190     -3.097779 
F        3.849425     -5.306064     -2.235067 
F       -0.616051     -5.914702      2.256893 
F        1.528813     -6.002717      2.615025 
F        0.628560     -7.291061      1.110961 
F       -5.869203      1.223072      2.779200 
F       -6.735885      2.731270      1.471575 
F       -4.902773      3.161625      2.570394 
F       -6.584443     -0.136570     -2.526907 
F       -4.669218     -0.842586     -3.292648 
F       -5.302070      1.207049     -3.661294 
S        0.009403      0.034169     -2.696421 
S       -0.043295     -0.079759      3.241550 
O       -0.932373     -1.204407      2.799335 
O        1.385606     -0.277328      2.827404 
136 
 
O       -0.576322      1.264187      2.837836 
C       -0.054451     -0.109925      5.044604 
H        0.589994      0.695028      5.404064 
H        0.322743     -1.081951      5.369082 
H       -1.082750      0.037785      5.381037 
 
Thiourea Catalyst 2-11 
Energy (kcal/mol):-1480032.09 
Job type: Single point. 
Method: RB3LYP 
Basis set: 6-31+G* 
Number of shells: 177 
Number of basis functions: 628 
Multiplicity: 1 
Coordinates (XYZ): 
 X  Y  Z 
C        0.000000      0.000000      0.247169 
C        4.270519      1.094513     -0.600500 
C        3.395253     -0.901622      1.125949 
C        2.923564      1.032493     -0.251415 
C        5.194294      0.174071     -0.093396 
C        4.746340     -0.817699      0.776016 
C        2.481704      0.021899      0.612949 
H        2.224230      1.761286     -0.639156 
H        6.240779      0.235222     -0.369543 
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H        3.055148     -1.695174      1.785260 
C       -4.270519     -1.094513     -0.600500 
C       -3.395253      0.901622      1.125949 
C       -5.194294     -0.174071     -0.093396 
C       -2.923564     -1.032493     -0.251415 
C       -2.481704     -0.021899      0.612949 
C       -4.746340      0.817699      0.776016 
H       -6.240779     -0.235222     -0.369543 
H       -2.224230     -1.761286     -0.639156 
H       -3.055148      1.695174      1.785260 
N        1.134252     -0.047417      1.041215 
H        1.006729     -0.439253      1.968273 
N       -1.134252      0.047417      1.041215 
H       -1.006729      0.439253      1.968273 
C        5.723410     -1.791359      1.386512 
C        4.749230      2.152849     -1.565536 
C       -5.723410      1.791359      1.386512 
C       -4.749230     -2.152849     -1.565536 
F        3.892747      3.196651     -1.649269 
F        5.957957      2.650916     -1.204358 
F        4.892101      1.655307     -2.820511 
F        6.834392     -1.946038      0.633637 
F        5.173678     -3.019878      1.555506 
F        6.134298     -1.379822      2.616597 
F       -6.134298      1.379822      2.616597 
138 
 
F       -6.834392      1.946038      0.633637 
F       -5.173678      3.019878      1.555506 
F       -5.957957     -2.650916     -1.204358 
F       -3.892747     -3.196651     -1.649269 
F       -4.892101     -1.655307     -2.820511 
S        0.000000      0.000000     -1.412840 
 
 
Thiourea Catalyst 2-11 + Mesylate 
Energy (kcal/mol): -1896642.93 
Job type: Single point.  
Method: RB3LYP 
Basis set: 6-31+G* 
Number of shells: 209 
Number of basis functions: 733 
Charge : -1  
Multiplicity: 1 
Coordinates (XYZ): 
 
 X  Y  Z 
C        0.007778     -0.728897     -0.084693 
C       -4.343415     -1.617060      0.692652 
C       -3.375901      0.593532     -0.686417 
C       -2.966388     -1.390787      0.642416 
C       -5.249046     -0.765620      0.057173 
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C       -4.746195      0.343879     -0.626421 
C       -2.467334     -0.281610     -0.061024 
H       -2.285575     -2.060342      1.147351 
H       -6.315109     -0.956757      0.098572 
H       -2.995089      1.468765     -1.203274 
C        4.411972     -1.655478     -0.606802 
C        3.386635      0.691371      0.468922 
C        5.294270     -0.706340     -0.095310 
C        3.027096     -1.462245     -0.584139 
C        2.497675     -0.284967     -0.031865 
C        4.760001      0.471508      0.437775 
H        6.364908     -0.873379     -0.112332 
H        2.365025     -2.214818     -0.986315 
H        2.983181      1.618719      0.864718 
N       -1.113337      0.069294     -0.123433 
H       -0.971052      1.076239     -0.329541 
N        1.137548      0.043229      0.028108 
H        0.982183      1.037723      0.278592 
C       -5.708810      1.307299     -1.267259 
C       -4.867844     -2.827352      1.418215 
C        5.706225      1.527049      0.944547 
C        4.952852     -2.954644     -1.141817 
F       -4.031997     -3.256092      2.394212 
F       -6.072683     -2.590795      2.007989 
F       -5.062314     -3.887095      0.582572 
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F       -6.809364      0.677847     -1.765317 
F       -5.156400      1.999786     -2.288896 
F       -6.176509      2.231152     -0.379006 
F        6.246878      2.260348     -0.069627 
F        6.763223      0.981012      1.611862 
F        5.119934      2.403881      1.788568 
F        6.229040     -2.839036     -1.599501 
F        4.213466     -3.448186     -2.164828 
F        4.982307     -3.927048     -0.186176 
S       -0.025474     -2.412307     -0.170634 
S        0.002866      3.645398      0.031812 
O        0.683763      4.646309     -0.814114 
O       -1.044412      2.827253     -0.681626 
O        0.929243      2.738776      0.806460 
C       -0.900061      4.571612      1.298294 
H       -1.421069      3.861758      1.944682 
H       -1.612919      5.229511      0.795716 
H       -0.178264      5.157310      1.872345 
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See figure 2.2 for X-ray of 2-10•2-31. A careful layering of cyclohexane on top of the 
solution of 2-10•2-31 produced X-ray quality crystals of colorless needles.  
A crystal dimentions 0.29x0.24x0.12 was mounted on a Bruker APEX-I CCD X-ray 
diffractometer equipped with a low temperature device and fine focus Mo-target X-ray tube (λ = 
0.71073 Å) operated at 1500 W power (50 kV, 30 mA). The X-ray intensities were measured at 
85(1) K; the detector was placed at a distance 5.081 cm from the crystal. A total of 4905 frames 
were collected with a scan width of 0.5° in ω and 0.45° in φ with an exposure time of 15 s/frame. 
The integration of the data yielded a total of 101188 reflections to a maximum 2θ value of 34.37° 
of which 16951 were independent and 13092 were greater than 2σ(I). The final unit cell constants 
of 2-10•2-31 (triclinic with space group symmetry P1) were a = 9.7859(2) Å, b = 12.3058(3) Å, c 
= 18.1842(4) Å; α = 70.4237(7)°, β = 85.3597(7)°, γ = 79.4903(7)°, V = 2028.15(8) Å3, Z = 2 for 
the formula C37H27F18N4O3PS2. All non-hydrogen atoms were refined anisotropically with the 
hydrogen atoms placed in the idealized positions. Refinement was performed using SHELXL-97 
by full-matrix least squares on F2. Full matrix least-squares refinement based on F2 converged at 
R1 = 0.0474 and wR2 = 0.1196 [based on I>2σ(I)], R1 = 0.0664, wR2 = 0.1338 for all data, GOF 
= 1.023. 
Chemical formula weight  1012.72  
Symmetry cell setting   Triclinic  
Symmetry space group name H-M P-1  
Cell length a    9.7859(2)  
Cell length b    12.3058(3)  
Cell length c    18.1842(4)  
Cell angle alpha   70.4237(7)  
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Cell angle beta   85.3597(7)  
Cell angle gamma   79.4903(7)  
Cell volume    2028.15(8)  
Cell formula units Z   2  
Cell measurement temperature 85(2)  
Cell measurement reflns_used 9849  
Cell measurement theta_min  2.38  
Cell measurement theta_max  34.26  
Exptl crystal description  plate  
Exptl crystal colour   colorless  
Exptl crystal size_max  0.29  
Exptl crystal size_mid  0.24  
Exptl crystal size_min  0.12  
Exptl crystal density_diffrn  1.658  
Exptl crystal density_method  'not measured'  
Exptl crystal _F_000   1020  
Exptl absorpt coefficient_mu  0.298  
Exptl absorpt correction type  multi-scan  
Exptl absorpt correction T min 0.9186  
Exptl absorpt correction T max 0.9651  
Exptl absorpt process details 
Blessing, R. Acta Cryst. (1995) A51 33-38. Sheldrick, G.  SADABS (Version 2008/1) 
Bruker AXS area detector absorption and other corrections, University of Gottingen, Germany 
2008. 
144 
 
Exptl specialdetails 4905 frames x 15 sec @ 5.081 cm; 0.5 deg omega scans; 0.45 deg phi 
scans; 
Diffrn ambient temperature  85(2)  
Diffrn radiation wavelength  0.71073  
Diffrn radiation type   MoK\a  
Diffrn radiation source  'fine-focus sealed tube'  
Diffrn radiation monochromator graphite  
Diffrn measurement device type 'Bruker APEX-I CCD'  
Diffrn measurement method  '\f and \w scans'  
Diffrn reflns number   101188  
Diffrn reflns av R equivalents 0.0534  
Diffrn reflns limit h min  -15  
Diffrn reflns limit h max  15  
Diffrn reflns limit k min  -19  
Diffrn reflns limit k max  19  
Diffrn reflns limit l min  -28  
Diffrn reflns limit l max  28  
Diffrn reflns theta min  1.78  
Diffrn reflns theta max  34.37  
Reflns number total   16951  
Reflns number gt   13092  
Reflns threshold expression  >2sigma(I)  
Computing data collection  'Bruker SMART'  
Computing cell refinement  'Bruker SAINT'  
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Computing data reduction  'Bruker SAINT'  
Computing structure solution  'SHELXS-97 (Sheldrick, 2008)'  
Computing structure refinement 'SHELXL-97 (Sheldrick, 2008)'  
Computing molecular graphics 'Bruker SHELXTL'  
Computing publication material 'Bruker SHELXTL'  
Refine special details: 
Two -CF3 groups are rotationally disordered.  Partial occupancy fluorine atoms were 
placed in two orientations.  SADI/SIMU/DELU restraints were employed to maintain chemical 
sensibility. For C31/F16/F17/F18, the disorder was adequately described by a 50/50 occupancy of 
the two orientations. For C23/F10/F11/F12, a free variable was refined for the site occupancy at 
values 0.703(5)/0.297(5).  
Refinement of F^2^ against ALL reflections.  The weighted R-factor wR and goodness of 
fit S are based on F^2^, conventional R-factors R are based on F, with F set to zero for negative 
F^2^. The threshold expression of F^2^ > 2sigma(F^2^) is used only for calculating R-factors(gt) 
etc. and is not relevant to the choice of reflections for refinement.  R-factors based on F^2^ are 
statistically about twice as large as those based on F, and R- factors based on ALL data will be 
even larger.  
Refine ls structure factor coef  Fsqd  
Refine ls matrix type   full  
Refine ls weighting scheme  calc  
Refine ls weighting details: 'calc w=1/[\s^2^(Fo^2^)+(0.0689P)^2^+0.9239P] where 
P=(Fo^2^+2Fc^2^)/3'  
Atom sites solution primary  direct  
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Atom sites solution secondary difmap  
Atom sites solution hydrogens geom  
Refine ls hydrogen treatment  mixed  
Refine ls extinction method  none  
Refine ls extinction coef  ?  
Refine ls number reflns  16951  
Refine ls number parameters  655  
Refine ls number restraints  30  
Refine ls R factor all   0.0664  
Refine ls R factor gt   0.0474  
Refine ls  wR factor ref  0.1338  
Refine ls wR factor gt   0.1196  
Refine ls goodness of fit ref  1.023  
Refine ls restrained S all  1.026  
Refine ls shift/su max   0.001  
Refine ls shift/su mean  0.000 
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